TW202035390A - Compound having pyrimidine ring structure and organic electroluminescent element - Google Patents
Compound having pyrimidine ring structure and organic electroluminescent element Download PDFInfo
- Publication number
- TW202035390A TW202035390A TW108137305A TW108137305A TW202035390A TW 202035390 A TW202035390 A TW 202035390A TW 108137305 A TW108137305 A TW 108137305A TW 108137305 A TW108137305 A TW 108137305A TW 202035390 A TW202035390 A TW 202035390A
- Authority
- TW
- Taiwan
- Prior art keywords
- unsubstituted
- substituted
- compound
- group
- organic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 126
- 125000000714 pyrimidinyl group Chemical group 0.000 title claims abstract description 65
- 239000000463 material Substances 0.000 claims abstract description 93
- 238000002347 injection Methods 0.000 claims abstract description 46
- 239000007924 injection Substances 0.000 claims abstract description 46
- 230000000903 blocking effect Effects 0.000 claims abstract description 40
- 239000010410 layer Substances 0.000 claims description 172
- -1 triphenylsilyl group Chemical group 0.000 claims description 39
- 125000001424 substituent group Chemical group 0.000 claims description 38
- 125000004432 carbon atom Chemical group C* 0.000 claims description 31
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims description 25
- 239000012044 organic layer Substances 0.000 claims description 24
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 20
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 14
- 125000004076 pyridyl group Chemical group 0.000 claims description 12
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 10
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 8
- 239000004305 biphenyl Substances 0.000 claims description 7
- 235000010290 biphenyl Nutrition 0.000 claims description 7
- 239000000470 constituent Substances 0.000 claims description 7
- 150000005041 phenanthrolines Chemical class 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 125000001041 indolyl group Chemical group 0.000 claims description 6
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 5
- 238000005401 electroluminescence Methods 0.000 claims description 5
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 claims description 5
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 5
- 125000002785 azepinyl group Chemical group 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 229910052805 deuterium Inorganic materials 0.000 claims description 4
- 125000004431 deuterium atom Chemical group 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 3
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 3
- 125000005493 quinolyl group Chemical group 0.000 claims description 3
- 125000005956 isoquinolyl group Chemical group 0.000 claims description 2
- 125000004957 naphthylene group Chemical group 0.000 claims 2
- 239000010409 thin film Substances 0.000 abstract description 17
- 229910052751 metal Inorganic materials 0.000 abstract description 10
- 239000002184 metal Substances 0.000 abstract description 10
- 150000002894 organic compounds Chemical class 0.000 abstract description 5
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract description 2
- 238000011156 evaluation Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 238000007740 vapor deposition Methods 0.000 description 37
- 239000010408 film Substances 0.000 description 35
- 239000000843 powder Substances 0.000 description 28
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 229940125898 compound 5 Drugs 0.000 description 21
- 239000012043 crude product Substances 0.000 description 21
- 238000004020 luminiscence type Methods 0.000 description 19
- 238000005259 measurement Methods 0.000 description 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 16
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 16
- 241000208340 Araliaceae Species 0.000 description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 description 15
- 235000008434 ginseng Nutrition 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- IBXMKLPFLZYRQZ-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 IBXMKLPFLZYRQZ-UHFFFAOYSA-N 0.000 description 14
- 238000005160 1H NMR spectroscopy Methods 0.000 description 14
- 238000005481 NMR spectroscopy Methods 0.000 description 14
- 150000001335 aliphatic alkanes Chemical class 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 238000001816 cooling Methods 0.000 description 14
- 229910052739 hydrogen Inorganic materials 0.000 description 14
- 239000001257 hydrogen Substances 0.000 description 14
- 239000012046 mixed solvent Substances 0.000 description 14
- 238000010992 reflux Methods 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 14
- 238000000151 deposition Methods 0.000 description 13
- 230000008021 deposition Effects 0.000 description 13
- 230000005525 hole transport Effects 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 238000004440 column chromatography Methods 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 8
- 235000019798 tripotassium phosphate Nutrition 0.000 description 8
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 7
- 239000003480 eluent Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 238000004528 spin coating Methods 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 239000002356 single layer Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 5
- 230000003111 delayed effect Effects 0.000 description 5
- 125000001624 naphthyl group Chemical group 0.000 description 5
- 125000005561 phenanthryl group Chemical group 0.000 description 5
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 4
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 4
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 4
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 4
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 description 4
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 4
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 4
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 description 4
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 229940125797 compound 12 Drugs 0.000 description 4
- 229940125851 compound 27 Drugs 0.000 description 4
- 229940125877 compound 31 Drugs 0.000 description 4
- 229940125878 compound 36 Drugs 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000009477 glass transition Effects 0.000 description 4
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- ABMYEXAYWZJVOV-UHFFFAOYSA-N pyridin-3-ylboronic acid Chemical compound OB(O)C1=CC=CN=C1 ABMYEXAYWZJVOV-UHFFFAOYSA-N 0.000 description 4
- 150000004322 quinolinols Chemical class 0.000 description 4
- LICBHZUERCHNFP-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-(4-naphthalen-1-ylphenyl)-6-(4-pyridin-3-ylphenyl)pyrimidine Chemical compound C1=CC=C2C(=C1)C=CC=C2C3=CC=C(C=C3)C4=NC(=CC(=N4)C5=CC=C(C=C5)Cl)C6=CC=C(C=C6)C7=CN=CC=C7 LICBHZUERCHNFP-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 150000001454 anthracenes Chemical class 0.000 description 3
- 150000001716 carbazoles Chemical class 0.000 description 3
- 239000002019 doping agent Substances 0.000 description 3
- 239000007772 electrode material Substances 0.000 description 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 3
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 125000001725 pyrenyl group Chemical group 0.000 description 3
- XJYYTJSLGQZIJU-UHFFFAOYSA-N pyridin-3-yloxyboronic acid Chemical compound OB(O)OC1=CC=CN=C1 XJYYTJSLGQZIJU-UHFFFAOYSA-N 0.000 description 3
- 125000004434 sulfur atom Chemical group 0.000 description 3
- 125000006617 triphenylamine group Chemical group 0.000 description 3
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 2
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 2
- UEXWQCOKZPOXEN-UHFFFAOYSA-N 2-(4-phenanthren-9-ylphenyl)-4,6-bis(4-pyridin-3-ylphenyl)pyrimidine Chemical compound C1=CC=CC=2C3=CC=CC=C3C(=CC1=2)C1=CC=C(C=C1)C1=NC(=CC(=N1)C1=CC=C(C=C1)C=1C=NC=CC=1)C1=CC=C(C=C1)C=1C=NC=CC=1 UEXWQCOKZPOXEN-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- AWXGSYPUMWKTBR-UHFFFAOYSA-N 4-carbazol-9-yl-n,n-bis(4-carbazol-9-ylphenyl)aniline Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(N(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 AWXGSYPUMWKTBR-UHFFFAOYSA-N 0.000 description 2
- VFUDMQLBKNMONU-UHFFFAOYSA-N 9-[4-(4-carbazol-9-ylphenyl)phenyl]carbazole Chemical group C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 VFUDMQLBKNMONU-UHFFFAOYSA-N 0.000 description 2
- 101000837344 Homo sapiens T-cell leukemia translocation-altered gene protein Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 2
- 102100028692 T-cell leukemia translocation-altered gene protein Human genes 0.000 description 2
- SLGBZMMZGDRARJ-UHFFFAOYSA-N Triphenylene Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=C1 SLGBZMMZGDRARJ-UHFFFAOYSA-N 0.000 description 2
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 description 2
- 150000007980 azole derivatives Chemical class 0.000 description 2
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical class C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 2
- 150000001556 benzimidazoles Chemical class 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 2
- UFVXQDWNSAGPHN-UHFFFAOYSA-K bis[(2-methylquinolin-8-yl)oxy]-(4-phenylphenoxy)alumane Chemical compound [Al+3].C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC([O-])=CC=C1C1=CC=CC=C1 UFVXQDWNSAGPHN-UHFFFAOYSA-K 0.000 description 2
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical group CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 2
- JGSNMAOUYKGBEM-UHFFFAOYSA-N c(cc12)ccc1-c1ccccc1C21c2cc(-c3nc(-c4cccc(-c5cnccc5)c4)cc(-c(cc4)ccc4-c4ccncc4)n3)ccc2-c2ccccc12 Chemical compound c(cc12)ccc1-c1ccccc1C21c2cc(-c3nc(-c4cccc(-c5cnccc5)c4)cc(-c(cc4)ccc4-c4ccncc4)n3)ccc2-c2ccccc12 JGSNMAOUYKGBEM-UHFFFAOYSA-N 0.000 description 2
- 229910052792 caesium Inorganic materials 0.000 description 2
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 125000004988 dibenzothienyl group Chemical group C1(=CC=CC=2SC3=C(C21)C=CC=C3)* 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N iso-quinoline Natural products C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- GDTOUTKTCGPAGY-UHFFFAOYSA-N isoquinolin-4-ylboronic acid Chemical compound C1=CC=C2C(B(O)O)=CN=CC2=C1 GDTOUTKTCGPAGY-UHFFFAOYSA-N 0.000 description 2
- 150000002537 isoquinolines Chemical class 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- DHHVAGZRUROJKS-UHFFFAOYSA-N phentermine Chemical compound CC(C)(N)CC1=CC=CC=C1 DHHVAGZRUROJKS-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- RONWGALEIBILOG-VMJVVOMYSA-N quinine sulfate Chemical compound [H+].[H+].[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 RONWGALEIBILOG-VMJVVOMYSA-N 0.000 description 2
- NVAZYEGEYOBDGY-UHFFFAOYSA-N quinolin-3-yloxyboronic acid Chemical compound C1=CC=CC2=CC(OB(O)O)=CN=C21 NVAZYEGEYOBDGY-UHFFFAOYSA-N 0.000 description 2
- KXJJSKYICDAICD-UHFFFAOYSA-N quinolin-8-ylboronic acid Chemical compound C1=CN=C2C(B(O)O)=CC=CC2=C1 KXJJSKYICDAICD-UHFFFAOYSA-N 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- DETFWTCLAIIJRZ-UHFFFAOYSA-N triphenyl-(4-triphenylsilylphenyl)silane Chemical compound C1=CC=CC=C1[Si](C=1C=CC(=CC=1)[Si](C=1C=CC=CC=1)(C=1C=CC=CC=1)C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 DETFWTCLAIIJRZ-UHFFFAOYSA-N 0.000 description 2
- 125000005580 triphenylene group Chemical group 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- XNCMQRWVMWLODV-UHFFFAOYSA-N 1-phenylbenzimidazole Chemical compound C1=NC2=CC=CC=C2N1C1=CC=CC=C1 XNCMQRWVMWLODV-UHFFFAOYSA-N 0.000 description 1
- ZABORCXHTNWZRV-UHFFFAOYSA-N 10-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenoxazine Chemical compound O1C2=CC=CC=C2N(C2=CC=C(C=C2)C2=NC(=NC(=N2)C2=CC=CC=C2)C2=CC=CC=C2)C2=C1C=CC=C2 ZABORCXHTNWZRV-UHFFFAOYSA-N 0.000 description 1
- IVCGJOSPVGENCT-UHFFFAOYSA-N 1h-pyrrolo[2,3-f]quinoline Chemical class N1=CC=CC2=C(NC=C3)C3=CC=C21 IVCGJOSPVGENCT-UHFFFAOYSA-N 0.000 description 1
- PRWATGACIORDEL-UHFFFAOYSA-N 2,4,5,6-tetra(carbazol-9-yl)benzene-1,3-dicarbonitrile Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=C(C#N)C(N2C3=CC=CC=C3C3=CC=CC=C32)=C(N2C3=CC=CC=C3C3=CC=CC=C32)C(N2C3=CC=CC=C3C3=CC=CC=C32)=C1C#N PRWATGACIORDEL-UHFFFAOYSA-N 0.000 description 1
- GVPODVKBTHCGFU-UHFFFAOYSA-N 2,4,6-tribromoaniline Chemical compound NC1=C(Br)C=C(Br)C=C1Br GVPODVKBTHCGFU-UHFFFAOYSA-N 0.000 description 1
- STTGYIUESPWXOW-UHFFFAOYSA-N 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline Chemical compound C=12C=CC3=C(C=4C=CC=CC=4)C=C(C)N=C3C2=NC(C)=CC=1C1=CC=CC=C1 STTGYIUESPWXOW-UHFFFAOYSA-N 0.000 description 1
- SWTLWNPJUHGCFR-UHFFFAOYSA-N 2-(10-phenylanthracen-9-yl)-4,6-bis(4-pyridin-3-ylphenyl)pyrimidine Chemical compound C1(=CC=CC=C1)C1=C2C=CC=CC2=C(C2=CC=CC=C12)C1=NC(=CC(=N1)C1=CC=C(C=C1)C=1C=NC=CC=1)C1=CC=C(C=C1)C=1C=NC=CC=1 SWTLWNPJUHGCFR-UHFFFAOYSA-N 0.000 description 1
- RIKNNBBGYSDYAX-UHFFFAOYSA-N 2-[1-[2-(4-methyl-n-(4-methylphenyl)anilino)phenyl]cyclohexyl]-n,n-bis(4-methylphenyl)aniline Chemical compound C1=CC(C)=CC=C1N(C=1C(=CC=CC=1)C1(CCCCC1)C=1C(=CC=CC=1)N(C=1C=CC(C)=CC=1)C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 RIKNNBBGYSDYAX-UHFFFAOYSA-N 0.000 description 1
- GEQBRULPNIVQPP-UHFFFAOYSA-N 2-[3,5-bis(1-phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole Chemical compound C1=CC=CC=C1N1C2=CC=CC=C2N=C1C1=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=C1 GEQBRULPNIVQPP-UHFFFAOYSA-N 0.000 description 1
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- OGGKVJMNFFSDEV-UHFFFAOYSA-N 3-methyl-n-[4-[4-(n-(3-methylphenyl)anilino)phenyl]phenyl]-n-phenylaniline Chemical compound CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 OGGKVJMNFFSDEV-UHFFFAOYSA-N 0.000 description 1
- IGOSXJLRUPAVMD-UHFFFAOYSA-N 4,6-bis(4-chlorophenyl)-2-(10-phenylanthracen-9-yl)pyrimidine Chemical compound ClC1=CC=C(C=C1)C1=NC(=NC(=C1)C1=CC=C(C=C1)Cl)C=1C2=CC=CC=C2C(=C2C=CC=CC=12)C1=CC=CC=C1 IGOSXJLRUPAVMD-UHFFFAOYSA-N 0.000 description 1
- RIMXPRDJSMIQAU-UHFFFAOYSA-N 4,6-bis(4-chlorophenyl)-2-(4-phenanthren-9-ylphenyl)pyrimidine Chemical compound ClC1=CC=C(C=C1)C1=NC(=NC(=C1)C1=CC=C(C=C1)Cl)C1=CC=C(C=C1)C=1C2=CC=CC=C2C=2C=CC=CC=2C=1 RIMXPRDJSMIQAU-UHFFFAOYSA-N 0.000 description 1
- PTXDLCXNWULUNW-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenanthren-2-yl-6-(3-pyridin-3-ylphenyl)pyrimidine Chemical compound ClC1=CC=C(C=C1)C1=NC(=NC(=C1)C1=CC(=CC=C1)C=1C=NC=CC=1)C1=CC=2C=CC3=CC=CC=C3C=2C=C1 PTXDLCXNWULUNW-UHFFFAOYSA-N 0.000 description 1
- ZOKIJILZFXPFTO-UHFFFAOYSA-N 4-methyl-n-[4-[1-[4-(4-methyl-n-(4-methylphenyl)anilino)phenyl]cyclohexyl]phenyl]-n-(4-methylphenyl)aniline Chemical compound C1=CC(C)=CC=C1N(C=1C=CC(=CC=1)C1(CCCCC1)C=1C=CC(=CC=1)N(C=1C=CC(C)=CC=1)C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 ZOKIJILZFXPFTO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- MZYDBGLUVPLRKR-UHFFFAOYSA-N 9-(3-carbazol-9-ylphenyl)carbazole Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC(N2C3=CC=CC=C3C3=CC=CC=C32)=CC=C1 MZYDBGLUVPLRKR-UHFFFAOYSA-N 0.000 description 1
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- 0 Bc1c(*)c(*)nc([Al])n1 Chemical compound Bc1c(*)c(*)nc([Al])n1 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000284156 Clerodendrum quadriloculare Species 0.000 description 1
- 229910000846 In alloy Inorganic materials 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- JZXXUZWBECTQIC-UHFFFAOYSA-N [Li].C1=CC=CC2=NC(O)=CC=C21 Chemical compound [Li].C1=CC=CC2=NC(O)=CC=C21 JZXXUZWBECTQIC-UHFFFAOYSA-N 0.000 description 1
- JHYLKGDXMUDNEO-UHFFFAOYSA-N [Mg].[In] Chemical compound [Mg].[In] JHYLKGDXMUDNEO-UHFFFAOYSA-N 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 125000003670 adamantan-2-yl group Chemical group [H]C1([H])C(C2([H])[H])([H])C([H])([H])C3([H])C([*])([H])C1([H])C([H])([H])C2([H])C3([H])[H] 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000001562 benzopyrans Chemical class 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IGFBYGSOACJQTA-UHFFFAOYSA-N c(cc1)cc2c1c(-c(cc1)ccc1-c1nc(-c(cc3)ccc3-c3cccnc3)cc(-c(cc3)ccc3-c3cncc4c3cccc4)n1)ccc2 Chemical compound c(cc1)cc2c1c(-c(cc1)ccc1-c1nc(-c(cc3)ccc3-c3cccnc3)cc(-c(cc3)ccc3-c3cncc4c3cccc4)n1)ccc2 IGFBYGSOACJQTA-UHFFFAOYSA-N 0.000 description 1
- RHNSASOQMULIPD-UHFFFAOYSA-N c(cc1)cc2c1c(cccc1)c1c(-c(cc1)ccc1-c1nc(-c(cc3)ccc3-c3cccc(-c4cnccc4)c3)cc(-c3cccnc3)n1)c2 Chemical compound c(cc1)cc2c1c(cccc1)c1c(-c(cc1)ccc1-c1nc(-c(cc3)ccc3-c3cccc(-c4cnccc4)c3)cc(-c3cccnc3)n1)c2 RHNSASOQMULIPD-UHFFFAOYSA-N 0.000 description 1
- LMSYFJNFXCSTPS-UHFFFAOYSA-N c(cc12)ccc1-c1ccccc1C21c(cc(cc2)-c3nc(-c4cccc(-c5cnccc5)c4)cc(-c(cc4)ccc4-c4cccc5c4nccc5)n3)c2-c2ccccc12 Chemical compound c(cc12)ccc1-c1ccccc1C21c(cc(cc2)-c3nc(-c4cccc(-c5cnccc5)c4)cc(-c(cc4)ccc4-c4cccc5c4nccc5)n3)c2-c2ccccc12 LMSYFJNFXCSTPS-UHFFFAOYSA-N 0.000 description 1
- VTZCRBLYDCVTTJ-UHFFFAOYSA-N c(cc12)ccc1-c1ccccc1C21c2cc(-c3nc(-c4cccc(-c5cnccc5)c4)cc(-c(cc4)ccc4-c4cnc(cccc5)c5c4)n3)ccc2-c2ccccc12 Chemical compound c(cc12)ccc1-c1ccccc1C21c2cc(-c3nc(-c4cccc(-c5cnccc5)c4)cc(-c(cc4)ccc4-c4cnc(cccc5)c5c4)n3)ccc2-c2ccccc12 VTZCRBLYDCVTTJ-UHFFFAOYSA-N 0.000 description 1
- WIGOZDOZEVDPAW-UHFFFAOYSA-N c(cc12)ccc1-c1ccccc1C21c2cc(-c3nc(-c4cccc(-c5cnccc5)c4)cc(-c(cc4)ccc4-c4cncc5c4cccc5)n3)ccc2-c2ccccc12 Chemical compound c(cc12)ccc1-c1ccccc1C21c2cc(-c3nc(-c4cccc(-c5cnccc5)c4)cc(-c(cc4)ccc4-c4cncc5c4cccc5)n3)ccc2-c2ccccc12 WIGOZDOZEVDPAW-UHFFFAOYSA-N 0.000 description 1
- XKTQDRBNRCMNPI-UHFFFAOYSA-N c(cc12)ccc1-c1ccccc1C21c2cc(-c3nc(-c4cnccc4)cc(-c(cc4)ccc4-c4ccccn4)n3)ccc2-c2ccccc12 Chemical compound c(cc12)ccc1-c1ccccc1C21c2cc(-c3nc(-c4cnccc4)cc(-c(cc4)ccc4-c4ccccn4)n3)ccc2-c2ccccc12 XKTQDRBNRCMNPI-UHFFFAOYSA-N 0.000 description 1
- CWNMOAIODCXGAN-UHFFFAOYSA-N c1ccc(C(c2ccccc2-c2c3)(c2ccc3-c2nc(-c(cc3)ccc3-c3cccnc3)cc(-c(cc3)ccc3-c3cnccc3)n2)c2ccccc2)cc1 Chemical compound c1ccc(C(c2ccccc2-c2c3)(c2ccc3-c2nc(-c(cc3)ccc3-c3cccnc3)cc(-c(cc3)ccc3-c3cnccc3)n2)c2ccccc2)cc1 CWNMOAIODCXGAN-UHFFFAOYSA-N 0.000 description 1
- TVPJWUJCVMKSEK-UHFFFAOYSA-N c1ccc(C2(c3cc(-c4nc(-c5cnccc5)cc(-c(cc5)ccc5-c5cnccc5)n4)ccc3-c3c2cccc3)c2ccccc2)cc1 Chemical compound c1ccc(C2(c3cc(-c4nc(-c5cnccc5)cc(-c(cc5)ccc5-c5cnccc5)n4)ccc3-c3c2cccc3)c2ccccc2)cc1 TVPJWUJCVMKSEK-UHFFFAOYSA-N 0.000 description 1
- PHAAUFWXTWZEAL-UHFFFAOYSA-N c1ccc2c3ccccc3c(-c(cc3)ccc3-c3nc(-c(cc4)ccc4-c(cc4)ccc4-c4cccnc4)cc(-c(cc4)ccc4-c4cccnc4)n3)cc2c1 Chemical compound c1ccc2c3ccccc3c(-c(cc3)ccc3-c3nc(-c(cc4)ccc4-c(cc4)ccc4-c4cccnc4)cc(-c(cc4)ccc4-c4cccnc4)n3)cc2c1 PHAAUFWXTWZEAL-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000004623 carbolinyl group Chemical group 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000010549 co-Evaporation Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 description 1
- XNMQEEKYCVKGBD-UHFFFAOYSA-N dimethylacetylene Chemical group CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- RBTKNAXYKSUFRK-UHFFFAOYSA-N heliogen blue Chemical compound [Cu].[N-]1C2=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=NC([N-]1)=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=N2 RBTKNAXYKSUFRK-UHFFFAOYSA-N 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- ORUIBWPALBXDOA-UHFFFAOYSA-L magnesium fluoride Chemical compound [F-].[F-].[Mg+2] ORUIBWPALBXDOA-UHFFFAOYSA-L 0.000 description 1
- 229910001635 magnesium fluoride Inorganic materials 0.000 description 1
- SJCKRGFTWFGHGZ-UHFFFAOYSA-N magnesium silver Chemical compound [Mg].[Ag] SJCKRGFTWFGHGZ-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- DCZNSJVFOQPSRV-UHFFFAOYSA-N n,n-diphenyl-4-[4-(n-phenylanilino)phenyl]aniline Chemical compound C1=CC=CC=C1N(C=1C=CC(=CC=1)C=1C=CC(=CC=1)N(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 DCZNSJVFOQPSRV-UHFFFAOYSA-N 0.000 description 1
- IBHBKWKFFTZAHE-UHFFFAOYSA-N n-[4-[4-(n-naphthalen-1-ylanilino)phenyl]phenyl]-n-phenylnaphthalen-1-amine Chemical compound C1=CC=CC=C1N(C=1C2=CC=CC=C2C=CC=1)C1=CC=C(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C3=CC=CC=C3C=CC=2)C=C1 IBHBKWKFFTZAHE-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000002987 phenanthrenes Chemical group 0.000 description 1
- XEXYATIPBLUGSF-UHFFFAOYSA-N phenanthro[9,10-b]pyridine-2,3,4,5,6,7-hexacarbonitrile Chemical group N1=C(C#N)C(C#N)=C(C#N)C2=C(C(C#N)=C(C(C#N)=C3)C#N)C3=C(C=CC=C3)C3=C21 XEXYATIPBLUGSF-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 150000003220 pyrenes Chemical class 0.000 description 1
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical class [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000005338 substituted cycloalkoxy group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 150000004867 thiadiazoles Chemical class 0.000 description 1
- 150000007979 thiazole derivatives Chemical class 0.000 description 1
- TVIVIEFSHFOWTE-UHFFFAOYSA-K tri(quinolin-8-yloxy)alumane Chemical compound [Al+3].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 TVIVIEFSHFOWTE-UHFFFAOYSA-K 0.000 description 1
- 125000005259 triarylamine group Chemical group 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/17—Carrier injection layers
- H10K50/171—Electron injection layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/622—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/624—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing six or more rings
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/626—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6576—Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
- H10K50/165—Electron transporting layers comprising dopants
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/18—Carrier blocking layers
Abstract
Description
本發明係關於適合用於屬於各種顯示裝置適用之自發光元件的有機電致發光元件(以下簡稱為「有機EL元件」)的化合物與有機EL元件;更詳之言,係關於具有嘧啶環構造之化合物、使用該化合物的有機EL元件。 The present invention relates to compounds and organic EL devices suitable for use in organic electroluminescence devices (hereinafter referred to as "organic EL devices") that are self-luminous devices applicable to various display devices; more specifically, it relates to having a pyrimidine ring structure The compound and the organic EL device using the compound.
有機EL元件由於為自發光性元件,故相較於液晶元件其明亮而辨視性優越,可進行鮮明顯示,故已被積極研究。 Since organic EL elements are self-luminous elements, they are brighter than liquid crystal elements, have better visibility, and can provide clear displays, so they have been actively studied.
於1987年伊士曼柯達公司之C.W.Tang等人係藉由開發出將各種角色分配至各材料之積層構造元件,而將使用了有機材料之有機EL元件實用化。C.W.Tang等人係將可輸送電子之螢光體與可輸送電洞之有機物積層,將兩者之電荷注入至螢光體之層之中使其發光,藉此依10V以下之電壓獲得1000cd/m2以上的高輝度(例如參照專利文獻1及專利文獻2)。
In 1987, CWTang and others of Eastman Kodak Company developed a multilayer structure element that assigns various roles to each material, and put the organic EL element using organic materials into practical use. CWTang et al. layered a phosphor that can transport electrons and an organic substance that can transport holes, and injected the charges of the two into the phosphor layer to make it emit light, thereby obtaining 1000 cd/m at a voltage below 10V. High brightness of 2 or more (for example, refer to
目前為止,為了有機EL元件之實用化已進行了許多改良,將積層構造之各種角色進一步細分化,藉由在基板上依序設置了陽極、電洞注入層、電洞輸送層、發光層、電子輸送層、電子注入層、陰極的電場發光元件可達成高效率與耐久性(例如參照非專利文獻1)。 So far, many improvements have been made for the practical application of organic EL devices. The various roles of the multilayer structure have been further subdivided. The anode, the hole injection layer, the hole transport layer, the light emitting layer, and the The electroluminescent element of the electron transport layer, the electron injection layer, and the cathode can achieve high efficiency and durability (for example, refer to Non-Patent Document 1).
此外,以進一步提高發光效率為目的,已嘗試有利用 三重態激子,研究磷光發光性化合物之利用(例如參照非專利文獻2)。 In addition, in order to further improve the luminous efficiency, it has tried to use The use of triplet excitons has been studied for phosphorescent compounds (for example, refer to Non-Patent Document 2).
而且,亦開發了利用藉由熱活化延遲螢光(Thermally activated delayed fluorescence;TADF)所致之發光的元件,2011年九州大學之安達等人,藉由使用了熱活化延遲螢光材料的元件實現了5.3%之外量子效率(例如參照非專利文獻3)。 In addition, they have also developed a device that utilizes the luminescence caused by thermally activated delayed fluorescence (TADF). In 2011, Kyushu University’s Anda et al. realized this by using a thermally activated delayed fluorescence material. Quantum efficiency other than 5.3% (for example, refer to Non-Patent Document 3).
發光層一般係於所謂主體材料之電荷輸送性之化合物摻雜螢光性化合物或磷光發光性化合物、或放射出延遲螢光之材料而可製作。上述非專利文獻所記載,有機EL元件中之有機材料之選擇將對此元件之效率或耐久性等各種特性造成大幅影響(例如參照非專利文獻2)。 The light-emitting layer is generally made by doping a fluorescent compound or a phosphorescent compound with a charge-transporting compound called a host material, or a material that emits delayed fluorescence. As described in the above non-patent literature, the selection of organic materials in the organic EL device will greatly affect the efficiency and durability of the device (for example, refer to Non-Patent Literature 2).
有機EL元件中,係由兩電極注入之電荷於發光層進行再結合而獲得發光,但重要的是如何效率佳地將電洞、電子之兩電荷傳遞至發光層。因此,藉由提高電子注入性、提高其移動度,而提升電洞與電子於發光層內進行再結合的機率,進而藉由將由陽極側所輸送之電洞封閉於發光層、防止電子輸送層之劣化、或將在發光層內所生成之激子封閉,創造更易再結合之環境,藉此可獲得高效率發光。因此,電子輸送材料所扮演的角色重要,需要有高電子注入性、高電子移動度、高電洞阻止性、進而對於電洞之耐久性高的電子輸送材料。 In an organic EL device, the charges injected by the two electrodes are recombined in the light-emitting layer to obtain light. However, what is important is how to efficiently transfer the two charges of holes and electrons to the light-emitting layer. Therefore, by improving the electron injection and mobility, the probability of recombination of holes and electrons in the light-emitting layer is increased, and the holes transported from the anode side are enclosed in the light-emitting layer to prevent the electron transport layer. Deterioration or sealing of excitons generated in the light-emitting layer to create an environment that is easier to recombine, thereby obtaining high-efficiency light. Therefore, the role of electron transport materials is important, and electron transport materials with high electron injection, high electron mobility, high hole blocking properties, and high durability against holes are required.
此外,關於元件之壽命,材料之耐熱性或非晶性亦重要。耐熱性低的材料係因元件驅動時所產生之熱,即使是低溫度亦引起熱分解而材料劣化。非晶性低的材料係即使短時間亦發生薄膜之結晶化,元件劣化。因此,對於所使用之材料要求耐熱性高、非 晶性良好的性質。 In addition, regarding the life of the device, the heat resistance or amorphousness of the material is also important. Materials with low heat resistance are due to the heat generated when the device is driven. Even low temperatures can cause thermal decomposition and deterioration of the material. A material with low amorphousness will crystallize the thin film even in a short time, and the device will deteriorate. Therefore, the materials used require high heat resistance, Good crystallinity.
代表性之發光材料的參(8-羥基喹啉)鋁(以下簡稱為Alq3)一般使用作為電子輸送材料,但其電子移動慢、且功函數為5.6eV,故難謂電洞阻止性能充分。 A typical luminescent material, ginseng (8-quinolinolato) aluminum (hereinafter referred to as Alq3) is generally used as an electron transport material, but its electron movement is slow and its work function is 5.6 eV, so it cannot be said that the hole blocking performance is sufficient.
作為經改良電子注入性或移動度等特性的化合物,已提案了具有苯并三唑構造之化合物(例如專利文獻3),但在將此等化合物用於電子輸送層之元件方面,發光效率等雖改良但仍不足,故仍要求進一步之低驅動電壓化、或進一步之高發光效率化。 As a compound with improved characteristics such as electron injection and mobility, a compound having a benzotriazole structure has been proposed (for example, Patent Document 3). However, in terms of using these compounds in an electron transport layer element, luminous efficiency, etc. Although the improvement is still insufficient, further lower driving voltage or higher luminous efficiency is still required.
又,作為電洞阻止性優異的電子輸送材料,提案有3-(4-聯苯基)-4-苯基-5-(4-第三丁基苯基)-1,2,4-三唑(以下簡稱為TAZ)(例如參照專利文獻4)。 In addition, as an electron transport material with excellent hole blocking properties, 3-(4-biphenyl)-4-phenyl-5-(4-tert-butylphenyl)-1,2,4-tri Azole (hereinafter referred to as TAZ) (for example, refer to Patent Document 4).
TAZ由於功函數高達6.6eV而電洞阻止能力高,故於藉由真空蒸鍍或塗佈等所製作之螢光發光層或磷光發光層中,被使用作為積層於陰極側之電子輸送性的電洞阻止層,有助於有機EL元件的高效率化(例如參照非專利文獻4)。 Since TAZ has a high work function of 6.6 eV and high hole blocking ability, it is used as an electron transporting layer laminated on the cathode side in a fluorescent light-emitting layer or a phosphorescent light-emitting layer produced by vacuum evaporation or coating. The hole blocking layer contributes to the improvement of the efficiency of the organic EL device (for example, refer to Non-Patent Document 4).
然而TAZ存在有電子輸送性低之重大課題,需要與電子輸送性高之電子輸送材料組合,以製作有機EL元件(例如參照非專利文獻5)。 However, TAZ has a major problem of low electron transport properties, and needs to be combined with electron transport materials with high electron transport properties to produce organic EL devices (for example, refer to Non-Patent Document 5).
再者,已知為電子輸送材料的2,9-二甲基-4,7-二苯基-1,10-啡啉(BCP)亦功函數高達6.7eV而電洞阻止能力高,但由於玻璃轉移點(Tg)低至83℃,故薄膜缺乏穩定性,難謂可作為電洞阻止層充分發揮機能。 Furthermore, 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (BCP), which is known as an electron transport material, has a work function of as high as 6.7 eV and high hole blocking ability, but due to The glass transition point (Tg) is as low as 83°C, so the film lacks stability, and it is hard to say that it can fully function as a hole blocking layer.
任一材料皆有膜穩定性不足、或阻止電洞之機能不足的情形。為了改善有機EL元件的元件特性,盼求一種電子之注入、 輸送性能與電洞阻止能力優良、薄膜狀態下之穩定性高的有機化合物。 Any material has insufficient membrane stability or insufficient function of preventing holes. In order to improve the device characteristics of organic EL devices, an injection of electrons, An organic compound with excellent transport performance and hole blocking ability and high stability in the film state.
[先前技術文獻] [Prior Technical Literature]
[專利文獻] [Patent Literature]
專利文獻1:美國專利US5792557 Patent Document 1: United States Patent US5792557
專利文獻2:美國專利US5639914 Patent Document 2: US Patent US5639914
專利文獻3:美國專利US9123897 Patent Document 3: US Patent US9123897
專利文獻4:美國專利US5869199 Patent Document 4: US Patent US5869199
專利文獻5:美國專利US2017/186967 Patent Document 5: US Patent US2017/186967
專利文獻6:美國專利US9199966 Patent Document 6: US Patent US9199966
專利文獻7:歐洲專利EP2684932 Patent Document 7: European Patent EP2684932
專利文獻8:美國專利US6878469 Patent Document 8: US Patent US6878469
專利文獻9:美國專利US8470454 Patent Document 9: US Patent US8470454
專利文獻10:美國專利US2017/186967 Patent Document 10: US Patent US2017/186967
[非專利文獻] [Non-Patent Literature]
非專利文獻1:應用物理學會第9屆講習會預稿集55~61頁(2001) Non-Patent Document 1: The 9th Workshop of the Society of Applied Physics, 55~61 pages (2001)
非專利文獻2:應用物理學會第9屆講習會預稿集23~31頁(2001) Non-Patent Document 2: Preliminary Collection of the 9th Seminar of the Applied Physics Society, 23~31 pages (2001)
非專利文獻3:Appl. Phys. Let., 98, 083302(2011) Non-Patent Document 3: Appl. Phys. Let., 98, 083302 (2011)
非專利文獻4:第50屆應用物理學相關聯合演講會28p-A-6演講預稿集1413頁(2003) Non-Patent Document 4: The 50th Joint Lecture on Applied Physics, 28p-A-6, 1413 pages (2003)
非專利文獻5:應用物理學會有機分子、生物電子學分科會會誌11卷1號13~19頁(2000)
Non-Patent Document 5: The Journal of the Organic Molecules and Bioelectronics Sub-committee of the Applied Physics Society, Volume 11,
非專利文獻6:J. Org. Chem. 2001, 66, 7125-7128 Non-Patent Document 6: J. Org. Chem. 2001, 66, 7125-7128
本發明之目的在於提供可作為高效率、高耐久性的有機EL元件用材料,電子注入、輸送性能優異、具有電洞阻止能力,於薄膜狀態下之穩定性高的具有優越特性的有機化合物;進而提供使用此化合物,而高效率、高耐久性的有機EL元件。 The purpose of the present invention is to provide an organic compound with superior characteristics that can be used as a high-efficiency and high-durability organic EL device material, has excellent electron injection and transport properties, has hole blocking ability, and has high stability in a thin film state; Furthermore, an organic EL element with high efficiency and high durability using this compound is provided.
作為本發明所欲提供之有機化合物應具備的物理性特性,可舉例如:(1)電子之注入特性佳、(2)電子之移動度大、(3)電洞阻止能力優異、(4)薄膜狀態穩定、(5)耐熱性優異。又,作為本發明所欲提供之有機EL元件應具備的物理性特性,可舉例如:(1)發光效率及電力效率高、(2)發光初始電壓低、(3)實用驅動電壓低、(4)壽命長。 As the physical properties of the organic compound to be provided by the present invention, for example: (1) good electron injection characteristics, (2) high mobility of electrons, (3) excellent hole blocking ability, (4) Stable film state, (5) Excellent heat resistance. In addition, as the physical characteristics of the organic EL device to be provided by the present invention, for example: (1) high luminous efficiency and power efficiency, (2) low light-emitting initial voltage, (3) low practical driving voltage, ( 4) Long life.
因此,本案發明人等為了達成上述目的,著眼於具電子親和性之嘧啶環中氮原子具有配位於金屬之能力、且耐熱性亦優異等特性,設計具有嘧啶環構造之化合物並化學合成,使用該化合物而試作各種有機EL元件,致力進行其特性評價,結果完成本案發明。 Therefore, in order to achieve the above-mentioned object, the inventors of the present case focused on the electron affinity of the nitrogen atom in the pyrimidine ring, which has the ability to coordinate with the metal and is excellent in heat resistance. They designed a compound with a pyrimidine ring structure and chemically synthesized it. The compound was tested as various organic EL devices, and the characteristics of the device were evaluated. As a result, the present invention was completed.
1)亦即本發明係下述一般式(a-1)所示之具有嘧啶環構造之化合物; 1) That is, the present invention is a compound having a pyrimidine ring structure represented by the following general formula (a-1);
[化1]
(式中,A及B彼此可為相同或不同,表示下述構造式(b-1),Ar表示取代或未取代之芳香族烴基、取代或未取代之芳香族雜環基、取代或未取代之縮合多環芳香族基。R表示氫原子、氘原子、氟原子、氯原子、氰基、硝基、三甲基矽烷基、三苯基矽烷基、取代或未取代之芳香族烴基、取代或未取代之芳香族雜環基、取代或未取代之縮合多環芳香族基、亦可具有取代基之碳原子數1~6之直鏈狀或分枝狀之烷基、亦可具有取代基之碳原子數5~10之環烷基、亦可具有取代基之碳原子數2~6之直鏈狀或分枝狀之烯基、亦可具有取代基之碳原子數1~6之直鏈狀或分枝狀之烷基氧基、或亦可具有取代基之碳原子數5~10之環烷基氧基;) (In the formula, A and B may be the same or different from each other, and represent the following structural formula (b-1), Ar represents a substituted or unsubstituted aromatic hydrocarbon group, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted Substituted condensed polycyclic aromatic group. R represents hydrogen atom, deuterium atom, fluorine atom, chlorine atom, cyano group, nitro group, trimethylsilyl group, triphenylsilyl group, substituted or unsubstituted aromatic hydrocarbon group, A substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted condensed polycyclic aromatic group, a linear or branched alkyl group with 1 to 6 carbon atoms that may have a substituent, and may also have Cycloalkyl groups with 5-10 carbon atoms as substituents, linear or branched alkenyl groups with 2-6 carbon atoms that may have substituents, and 1-6 carbon atoms that may also have substituents The straight-chain or branched alkyloxy group, or the cycloalkyloxy group with 5-10 carbon atoms which may also have substituents;)
[化2]----L──Het (b-1) [化2] ----L──Het (b-1)
(式中,L表示單鍵、取代或未取代之芳香族烴基、取代或未取代之芳香族雜環基、或取代或未取代之縮合多環芳香族基之2價基;Het表示取代或未取代之吡啶基、取代或未取代之嘧啶基、取代或未取代之三基、取代或未取代之喹啉基、取代或未取代之異喹啉基、取代或未取代之啡啉基、取代或未取代之吲哚基、取代或 未取代之氮雜茀基、取代或未取代之二氮雜茀基、取代或未取代之氮雜螺二茀基、或取代或未取代之二氮雜螺二茀基,虛線表示與嘧啶環間之鍵結部位。) (In the formula, L represents a single bond, a substituted or unsubstituted aromatic hydrocarbon group, a substituted or unsubstituted aromatic heterocyclic group, or a substituted or unsubstituted divalent group of a condensed polycyclic aromatic group; Het represents a substituted or Unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted three Group, substituted or unsubstituted quinolinyl, substituted or unsubstituted isoquinolinyl, substituted or unsubstituted phenanthroline, substituted or unsubstituted indolyl, substituted or unsubstituted azepinyl, substituted Or unsubstituted diazaspirodiazepine group, substituted or unsubstituted azaspirodiazepine group, or substituted or unsubstituted diazaspirodiazepine group, the dotted line indicates the bonding site with the pyrimidine ring. )
2),又,本發明係上述1)記載之具有嘧啶環構造之化合物,係以下述一般式(a-2)所示; 2) In addition, the present invention is a compound having a pyrimidine ring structure described in 1) above, and is represented by the following general formula (a-2);
[化3]
(式中,A、B、Ar及R係與上述一般式(a-1)相同意義。) (In the formula, A, B, Ar and R have the same meaning as the above general formula (a-1).)
3),又,本發明係上述1)記載之具有嘧啶環構造之化合物,係以下述一般式(a-3)所示; 3) In addition, the present invention is a compound having a pyrimidine ring structure described in 1) above, which is represented by the following general formula (a-3);
[化4]
(式中,A、B、Ar及R係與上述一般式(a-1)相同意義。) (In the formula, A, B, Ar and R have the same meaning as the above general formula (a-1).)
4),又,本發明係上述2)記載之具有嘧啶環構造之化合物,上述A及B彼此不同。 4) In addition, the present invention is a compound having a pyrimidine ring structure described in 2) above, and the above A and B are different from each other.
5),又,本發明係上述3)記載之具有嘧啶環構造之化 合物,上述A及B彼此不同。 5) In addition, the present invention is a chemical compound having a pyrimidine ring structure described in 3) above The above-mentioned A and B are different from each other.
6),又,本發明係上述4)記載之具有嘧啶環構造之化合物,上述構造式(b-1)中之L表示單鍵、取代或未取代之苯基、取代或未取代之萘基、取代或未取代之蒽基、取代或未取代之菲基、或取代或未取代之聯苯基。 6) In addition, the present invention is a compound having a pyrimidine ring structure as described in 4) above. In the above structural formula (b-1), L represents a single bond, a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group , Substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthryl, or substituted or unsubstituted biphenyl.
7),又,本發明係上述5)記載之具有嘧啶環構造之化合物,上述構造式(b-1)中之L表示單鍵、取代或未取代之苯基、取代或未取代之萘基、取代或未取代之蒽基、取代或未取代之菲基、或取代或未取代之聯苯基。 7) In addition, the present invention is a compound having a pyrimidine ring structure as described in 5) above. In the above structural formula (b-1), L represents a single bond, a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group , Substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthryl, or substituted or unsubstituted biphenyl.
8),又,本發明係上述6)記載之具有嘧啶環構造之化合物,上述構造式(b-1)中之Het表示未取代之吡啶基、未取代之喹啉基、未取代之異喹啉基、或未取代之啡啉基。 8) In addition, the present invention is a compound having a pyrimidine ring structure described in 6) above, and Het in the above structural formula (b-1) represents an unsubstituted pyridyl group, an unsubstituted quinolinyl group, and an unsubstituted isoquinoline Linyl, or unsubstituted phenanthroline.
9),又,本發明係上述7)記載之具有嘧啶環構造之化合物,上述構造式(b-1)中之Het表示未取代之吡啶基、未取代之喹啉基、未取代之異喹啉基、或未取代之啡啉基。 9) In addition, the present invention is a compound having a pyrimidine ring structure as described in 7) above. The Het in the above structural formula (b-1) represents an unsubstituted pyridyl group, an unsubstituted quinolinyl group, and an unsubstituted isoquinoline Linyl, or unsubstituted phenanthroline.
10),又,本發明為一種有機EL元件,係具有一對電極、與挾持於其間之至少一層的有機層者;其特徵為,上述1)~9)中任一項所記載之具有嘧啶環構造之化合物係使用作為至少1層之有機層的構成材料。 10) In addition, the present invention is an organic EL device having a pair of electrodes and at least one organic layer sandwiched therebetween; it is characterized in that any one of 1) to 9) has a pyrimidine The compound of the ring structure is used as a constituent material of at least one organic layer.
11),又,本發明係上述10)記載之有機EL元件,係上述使用具有嘧啶環構造之化合物之有機層為電子輸送層。 11) In addition, the present invention is the organic EL device described in 10), wherein the organic layer using the compound having a pyrimidine ring structure is an electron transport layer.
12),又,本發明係上述10)記載之有機EL元件,係上述使用具有嘧啶環構造之化合物之有機層為電洞阻止層。 12) In addition, the present invention is the organic EL device described in 10), wherein the organic layer using a compound having a pyrimidine ring structure is a hole blocking layer.
13),又,本發明係上述10)記載之有機EL元件,係 上述使用具有嘧啶環構造之化合物之有機層為發光層。 13). Furthermore, the present invention is the organic EL device described in 10) above, which is The above-mentioned organic layer using a compound having a pyrimidine ring structure is a light-emitting layer.
14),又,本發明係上述10)記載之有機EL元件,係上述使用具有嘧啶環構造之化合物之有機層為電子注入層。 14) In addition, the present invention is the organic EL device described in 10), wherein the organic layer using the compound having a pyrimidine ring structure is an electron injection layer.
1:玻璃基板 1: glass substrate
2:透明陽極 2: Transparent anode
3:電洞注入層 3: hole injection layer
4:電洞輸送層 4: Electric hole transport layer
5:發光層 5: Light-emitting layer
6:電洞阻止層 6: Hole blocking layer
7:電子輸送層 7: Electron transport layer
8:電子注入層 8: Electron injection layer
9:陰極 9: Cathode
圖1為表示實施例17~30、比較例1~4之有機EL元件構成的圖。 Fig. 1 is a diagram showing the configuration of organic EL devices of Examples 17 to 30 and Comparative Examples 1 to 4.
本發明之具有嘧啶環構造之化合物,係下述一般式(a-1)所示化合物。 The compound having a pyrimidine ring structure of the present invention is a compound represented by the following general formula (a-1).
[化5]
(式中,A及B彼此可為相同或不同,表示下述構造式(b-1),Ar表示取代或未取代之芳香族烴基、取代或未取代之芳香族雜環基、取代或未取代之縮合多環芳香族基。R表示氫原子、氘原子、氟原子、氯原子、氰基、硝基、三甲基矽烷基、三苯基矽烷基、取代或未取代之芳香族烴基、取代或未取代之芳香族雜環基、取代或未取代之縮合多環芳香族基、亦可具有取代基之碳原子數1~6之直鏈狀或分枝狀之烷基、亦可具有取代基之碳原子數5~10之環烷基、亦可具有取代基之碳原子數2~6之直鏈狀或分枝狀之烯基、亦可具有取代基之碳原子數1~6之直鏈狀或分枝狀之烷基氧基、或亦可具 有取代基之碳原子數5~10之環烷基氧基;) (In the formula, A and B may be the same or different from each other, and represent the following structural formula (b-1), Ar represents a substituted or unsubstituted aromatic hydrocarbon group, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted Substituted condensed polycyclic aromatic group. R represents hydrogen atom, deuterium atom, fluorine atom, chlorine atom, cyano group, nitro group, trimethylsilyl group, triphenylsilyl group, substituted or unsubstituted aromatic hydrocarbon group, A substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted condensed polycyclic aromatic group, a linear or branched alkyl group with 1 to 6 carbon atoms that may have a substituent, and may also have Cycloalkyl groups with 5-10 carbon atoms as substituents, linear or branched alkenyl groups with 2-6 carbon atoms that may have substituents, and 1-6 carbon atoms that may also have substituents The linear or branched alkyloxy group, or can also have Substituted cycloalkyloxy group with 5 to 10 carbon atoms;)
[化6]----L──Het (b-1) [化6] ----L──Het (b-1)
(式中,L表示單鍵、取代或未取代之芳香族烴基、取代或未取代之芳香族雜環基、或取代或未取代之縮合多環芳香族基之2價基;Het表示取代或未取代之吡啶基、取代或未取代之嘧啶基、取代或未取代之三基、取代或未取代之喹啉基、取代或未取代之異喹啉基、取代或未取代之啡啉基、取代或未取代之吲哚基、取代或未取代之氮雜茀基、取代或未取代之二氮雜茀基、取代或未取代之氮雜螺二茀基、或取代或未取代之二氮雜螺二茀基,虛線表示與嘧啶環間之鍵結部位。) (In the formula, L represents a single bond, a substituted or unsubstituted aromatic hydrocarbon group, a substituted or unsubstituted aromatic heterocyclic group, or a substituted or unsubstituted divalent group of a condensed polycyclic aromatic group; Het represents a substituted or Unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted three Group, substituted or unsubstituted quinolinyl, substituted or unsubstituted isoquinolinyl, substituted or unsubstituted phenanthroline, substituted or unsubstituted indolyl, substituted or unsubstituted azepinyl, substituted Or unsubstituted diazaspirodiazepine group, substituted or unsubstituted azaspirodiazepine group, or substituted or unsubstituted diazaspirodiazepine group, the dotted line indicates the bonding site with the pyrimidine ring. )
上述一般式(a-1)中之Ar、R所示「取代或未取代之芳香族烴基」、「取代或未取代之芳香族雜環基」及「取代或未取代之縮合多環芳香族基」中之「芳香族烴基」、「芳香族雜環基」及「縮合多環芳香族基」,具體可舉例如:苯基、聯苯基、三苯基、萘基、蒽基、菲基、茀基、螺二茀基、茚基、芘基、苝基、丙(二)烯合茀基、聯伸三苯基、吡啶基、嘧啶基、三吖基、呋喃基、吡咯基、噻吩基、喹啉基、異喹啉基、苯并呋喃基、苯并噻吩基、吲哚基、咔唑基、苯并唑基、苯并噻唑基、氮雜茀基、二氮雜茀基、氮雜螺二茀基、二氮雜螺二茀基、喹啉基、苯并咪唑基、吡唑基、二苯并呋喃基、二苯并噻吩基、萘啶基、啡啉基、吖啶基、及咔啉基等,尚有由碳數6~30所構成之芳基、及由碳數2~20所構成之雜芳 基等。 In the above general formula (a-1), "substituted or unsubstituted aromatic hydrocarbon group", "substituted or unsubstituted aromatic heterocyclic group" and "substituted or unsubstituted condensed polycyclic aromatic group" represented by Ar and R "Aromatic hydrocarbon group", "aromatic heterocyclic group" and "condensed polycyclic aromatic group" in "group", specific examples include: phenyl, biphenyl, triphenyl, naphthyl, anthracenyl, phenanthrene Group, stilbene, spirodiphenyl, indenyl, pyrenyl, perylene, propylene(di)ene pyrenyl, triphenylene, pyridyl, pyrimidinyl, triacrine Group, furyl, pyrrolyl, thienyl, quinolinyl, isoquinolinyl, benzofuranyl, benzothienyl, indolyl, carbazolyl, benzo Azolyl, benzothiazolyl, azapyridine, diazapyridinium, azaspirodipyridinium, diazaspirodipyridinium, quine Alrinyl, benzimidazolyl, pyrazolyl, dibenzofuranyl, dibenzothienyl, naphthyridinyl, phenanthroline, acridinyl, and carboline group, etc., with carbon numbers 6~30 The formed aryl group, and the heteroaryl group composed of 2-20 carbons, etc.
上述一般式(a-1)中的Ar、R所示之「取代芳香族烴基」、「取代芳香族雜環基」及「取代縮合多環芳香族基」中之「取代基」,具體可舉例如:氘原子、氰基、硝基;氟原子、氯原子、溴原子、碘原子等鹵素原子;三甲基矽烷基、三苯基矽烷基等矽烷基;甲基、乙基、丙基等碳原子數1至6之直鏈狀或分枝狀的烷基;甲氧基、乙氧基、丙氧基等碳原子數1至6之直鏈狀或分枝狀的烷基氧基;乙烯基、烯丙基等烯基;苯氧基、甲苯氧基等芳氧基;苄氧基、苯乙氧基等芳基烷基氧基;苯基、聯苯基、三苯基、萘基、蒽基、菲基、茀基、螺二茀基、茚基、芘基、苝基、丙(二)烯合茀基、聯伸三苯基等芳香族烴基或縮合多環芳香族基;吡啶基、噻吩基、呋喃基、吡咯基、喹啉基、異喹啉基、苯并呋喃基、苯并噻吩基、吲哚基、咔唑基、苯并唑基、苯并噻唑基、喹啉基、苯并咪唑基、吡唑基、二苯并呋喃基、二苯并噻吩基、咔啉基等芳香族雜環基。此等取代基亦可進一步由上述例示取代基所取代。又,經此等取代基所取代之苯環、或於同一苯環上經複數取代之取代基彼此,亦可經由單鍵、取代或未取代之亞甲基、氧原子或硫原子而彼此鍵結形成環。 The "substituent" in the "substituted aromatic hydrocarbon group", "substituted aromatic heterocyclic group" and "substituted condensed polycyclic aromatic group" represented by Ar and R in the above general formula (a-1) can be specifically For example: deuterium atom, cyano group, nitro group; halogen atom such as fluorine atom, chlorine atom, bromine atom, iodine atom; silyl group such as trimethylsilyl group and triphenylsilyl group; methyl group, ethyl group, propyl group Linear or branched alkyl with 1 to 6 carbon atoms; methoxy, ethoxy, propoxy and other linear or branched alkyloxy with 1 to 6 carbon atoms ; Alkenyl such as vinyl and allyl; aryloxy such as phenoxy and tolyloxy; arylalkyloxy such as benzyloxy and phenethoxy; phenyl, biphenyl, triphenyl, Aromatic hydrocarbon groups such as naphthyl, anthracenyl, phenanthryl, stilbyl, spirodiphenyl, indenyl, pyrenyl, perylene, propenyl, triphenylene and other aromatic hydrocarbon groups or condensed polycyclic aromatic groups ; Pyridyl, thienyl, furanyl, pyrrolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzothienyl, indolyl, carbazolyl, benzo Azolyl, benzothiazolyl, quine Aromatic heterocyclic groups such as olinyl, benzimidazolyl, pyrazolyl, dibenzofuranyl, dibenzothienyl, and carbolinyl. These substituents may be further substituted with the above-exemplified substituents. In addition, the benzene ring substituted by these substituents, or the plural substituted substituents on the same benzene ring, may also be bonded to each other via a single bond, a substituted or unsubstituted methylene group, an oxygen atom or a sulfur atom The knot forms a ring.
上述一般式(a-1)中的R所示之「亦可具有取代基之碳原子數1~6之直鏈狀或分枝狀之烷基」、「亦可具有取代基之碳原子數5~10之環烷基」及「碳原子數1~6之直鏈狀或分枝狀之烷基」中之「碳原子數1~6之直鏈狀或分枝狀之烷基」、「碳原子數5~10之環烷基」及「碳原子數2~6之直鏈狀或分枝狀之烯基」,具體可舉例如甲基、乙基、正丙基、異丙基、正丁基、異丁基、第三丁基、 正戊基、異戊基、新戊基、正己基、環戊基、環己基、1-金剛烷基、2-金剛烷基、乙烯基、烯丙基、異丙烯基、及2-丁烯基等。經此等取代基所取代之苯環、或於同一苯環上經複數取代之取代基彼此,亦可經由單鍵、取代或未取代之亞甲基、取代或未取代之胺基、氧原子或硫原子而彼此鍵結形成環。 In the above general formula (a-1), the "linear or branched alkyl group with 1 to 6 carbon atoms which may have substituents" represented by R in the above general formula (a-1), "the number of carbon atoms which may also have substituents "5-10 cycloalkyl" and "linear or branched alkyl with 1 to 6 carbon atoms", "linear or branched alkyl with 1 to 6 carbon atoms", "Cycloalkyl with 5 to 10 carbon atoms" and "Straight-chain or branched alkenyl with 2 to 6 carbon atoms", specific examples include methyl, ethyl, n-propyl, isopropyl , N-butyl, isobutyl, tertiary butyl, N-pentyl, isopentyl, neopentyl, n-hexyl, cyclopentyl, cyclohexyl, 1-adamantyl, 2-adamantyl, vinyl, allyl, isopropenyl, and 2-butene Base etc. The benzene ring substituted by these substituents, or the plural substituted substituents on the same benzene ring, can also be through a single bond, substituted or unsubstituted methylene, substituted or unsubstituted amine group, and oxygen atom Or sulfur atoms are bonded to each other to form a ring.
上述一般式(a-1)中的R所示之「亦可具有取代基之碳原子數1~6之直鏈狀或分枝狀之烷基」、「亦可具有取代基之碳原子數5~10之環烷基」及「亦可具有取代基之碳原子數2~6之直鏈狀或分枝狀之烯基」中之「取代基」,具體可舉例如與一般式(a-1)中的Ar、R所示之「取代芳香族烴基」、「取代芳香族雜環基」及「取代縮合多環芳香族基」中之「取代基」所例示相同者,所有態樣亦可舉例如相同者。 In the above general formula (a-1), the "linear or branched alkyl group with 1 to 6 carbon atoms which may have substituents" represented by R in the above general formula (a-1), "the number of carbon atoms which may also have substituents The "substituent" in the "5-10 cycloalkyl group" and "the linear or branched alkenyl group with 2-6 carbon atoms that may have substituents", specifically, for example, the general formula (a -1) In the "substituted aromatic hydrocarbon group", "substituted aromatic heterocyclic group" and "substituted condensed polycyclic aromatic group" in the "substituted aromatic hydrocarbon group", "substituted condensed polycyclic aromatic group" in -1), the same examples, all aspects For example, the same ones may also be mentioned.
上述一般式(a-1)中的R所示之「亦可具有取代基之碳原子數1~6之直鏈狀或分枝狀之烷基氧基」及「亦可具有取代基之碳原子數5~10之環烷基氧基」中之「碳原子數1~6之直鏈狀或分枝狀之烷基氧基」及「碳原子數5~10之環烷基氧基」,具體可舉例如:甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、第三丁氧基、正戊氧基、正己氧基、環戊氧基、環己氧基、環庚氧基、環辛氧基、1-金剛烷基氧基、2-金剛烷基氧基等。經此等取代基所取代之苯環、或於同一苯環上經複數取代之取代基彼此,亦可經由單鍵、取代或未取代之亞甲基、取代或未取代之胺基、氧原子或硫原子而彼此鍵結形成環。 In the above general formula (a-1), the "linear or branched alkyloxy group having 1 to 6 carbon atoms which may also have substituents" and "the carbon which may have substituents "Cycloalkyloxy group with 5 to 10 atoms" in "Linear or branched alkyloxy group with 1 to 6 carbon atoms" and "Cycloalkyloxy group with 5 to 10 carbon atoms" Specific examples include: methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, tertiary butoxy, n-pentyloxy, n-hexyloxy, cyclopentyloxy, ring Hexyloxy, cycloheptyloxy, cyclooctyloxy, 1-adamantyloxy, 2-adamantyloxy and the like. The benzene ring substituted by these substituents, or the plural substituted substituents on the same benzene ring, can also be through a single bond, substituted or unsubstituted methylene, substituted or unsubstituted amine group, and oxygen atom Or sulfur atoms are bonded to each other to form a ring.
上述一般式(a-1)中的R所示之「亦可具有取代基之碳原子數1~6之直鏈狀或分枝狀之烷基氧基」及「亦可具有取代基之 碳原子數5~10之環烷基氧基」中之「取代基」,具體可舉例如與一般式(a-1)中的Ar、R所示之「取代芳香族烴基」、「取代芳香族雜環基」及「取代縮合多環芳香族基」中之「取代基」所例示相同者,所有態樣亦可舉例如相同者。 In the above general formula (a-1), the "linear or branched alkyloxy group having 1 to 6 carbon atoms which may also have substituents" and "the alkyloxy group which may have substituents Specific examples of the "substituent" in the "cycloalkyloxy group having 5 to 10 carbon atoms" include the "substituted aromatic hydrocarbon group" and "substituted aromatic hydrocarbon group" represented by Ar and R in the general formula (a-1). The "substituent" in the "group heterocyclic group" and "substituted condensed polycyclic aromatic group" is the same as exemplified, and all aspects can be, for example, the same.
上述構造式(b-1)中的L所示之「取代或未取代之芳香族烴基」、「取代或未取代之芳香族雜環基」及「取代或未取代之縮合多環芳香族基」中之「芳香族烴基」、「芳香族雜環基」及「縮合多環芳香族基」,可舉例如由一般式(a-1)中的Ar、R所示之「取代或未取代之芳香族烴基」、「取代或未取代之芳香族雜環基」及「取代或未取代之縮合多環芳香族基」中之「芳香族烴基」、「芳香族雜環基」及「縮合多環芳香族基」所例示者去除了1個氫原子的2價基,所有態樣亦可舉例如相同者。 The "substituted or unsubstituted aromatic hydrocarbon group", "substituted or unsubstituted aromatic heterocyclic group" and "substituted or unsubstituted condensed polycyclic aromatic group" represented by L in the above structural formula (b-1) "Aromatic hydrocarbon group", "aromatic heterocyclic group" and "condensed polycyclic aromatic group" in ", for example, "substituted or unsubstituted" represented by Ar and R in general formula (a-1) "Aromatic hydrocarbon group", "substituted or unsubstituted aromatic heterocyclic group" and "substituted or unsubstituted condensed polycyclic aromatic group" in the "aromatic hydrocarbon group", "aromatic heterocyclic group" and "condensation The "polycyclic aromatic group" exemplifies a divalent group in which one hydrogen atom is removed, and all aspects may be, for example, the same.
上述構造式(b-1)中的L所示之「取代芳香族烴基」、「取代芳香族雜環基」及「取代縮合多環芳香族基」中之「取代基」,具體可舉例如與一般式(a-1)中的Ar、R所示之「取代芳香族烴基」、「取代芳香族雜環基」及「取代縮合多環芳香族基」中之「取代基」所例示相同者,所有態樣亦可舉例如相同者。 The "substituent" in the "substituted aromatic hydrocarbon group", "substituted aromatic heterocyclic group", and "substituted condensed polycyclic aromatic group" represented by L in the above structural formula (b-1), specifically, for example The same as the examples of the "substituent" in the "substituted aromatic hydrocarbon group", "substituted aromatic heterocyclic group" and "substituted condensed polycyclic aromatic group" represented by Ar and R in general formula (a-1) In addition, all aspects may be the same, for example.
上述構造式(b-1)中的Het表示之「取代吡啶基」、「取代嘧啶基」、「取代三基」、「取代喹啉基」、「取代異喹啉基」、「取代啡啉基」、「取代吲哚基」、「取代氮雜茀基」、「取代二氮雜茀基」、「取代氮雜螺二茀基」及「取代二氮雜螺二茀基」中之「取代基」,具體可舉例如與一般式(a-1)中的Ar、R所示之「取代芳香族烴基」、「取代芳香族雜環基」及「取代縮合多環芳香族基」中之「取代基」所例示相同者,所有態樣亦可舉例如相同者。 The "substituted pyridyl", "substituted pyrimidinyl", "substituted three" represented by Het in the above structural formula (b-1) "Group", "Substituted quinolinyl", "Substituted isoquinolinyl", "Substituted phenanthryl", "Substituted indolyl", "Substituted azepinyl", "Substituted diazepinyl", " The "substituents" in "substituted azaspirodisyl" and "substituted diazaspirodisyl" can be specifically exemplified with the "substituted aromatics" represented by Ar and R in general formula (a-1) The examples of the "substituent" in the "hydrocarbon group", "substituted aromatic heterocyclic group" and "substituted condensed polycyclic aromatic group" are the same, and all aspects may be, for example, the same.
本發明中,由電子注入、輸送性能、電洞阻止能力、薄膜狀態下之穩定性等觀點而言,上述一般式(a-1)中之Ar較佳為取代或未取代之芳香族烴基、或取代或未取代之縮合多環芳香族基,更佳為取代或未取代之伸苯基、取代或未取代之伸蒽基、取代或未取代之伸菲基、取代或未取代之茀基或取代或未取代之螺二茀基。 In the present invention, from the viewpoints of electron injection, transport performance, hole blocking ability, and stability in a thin film state, Ar in the above general formula (a-1) is preferably a substituted or unsubstituted aromatic hydrocarbon group, Or substituted or unsubstituted condensed polycyclic aromatic group, more preferably substituted or unsubstituted phenylene, substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthrenyl, substituted or unsubstituted phenanthrenyl Or substituted or unsubstituted spirodiphenyl.
又,R較佳為氫原子。 Moreover, R is preferably a hydrogen atom.
本發明中,由電子注入、輸送性能、電洞阻止能力、薄膜狀態下之穩定性等觀點而言,上述構造式(b-1)L較佳為單鍵、取代或未取代之伸苯基、取代或未取代之萘基、取代或未取代之蒽基、取代或未取代之菲基、或取代或未取代之聯苯基,較佳為未取代之伸苯基。 In the present invention, from the viewpoints of electron injection, transport performance, hole blocking ability, and stability in a thin film state, the above structural formula (b-1) L is preferably a single bond, substituted or unsubstituted phenylene , Substituted or unsubstituted naphthyl, substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthryl, or substituted or unsubstituted biphenyl, preferably unsubstituted phenylene.
又,Het較佳為未取代之吡啶基、未取代之喹啉基或未取代之異喹啉基。 In addition, Het is preferably an unsubstituted pyridyl group, an unsubstituted quinolyl group or an unsubstituted isoquinolyl group.
由電子注入、輸送性能、電洞阻止能力、薄膜狀態下之穩定性等觀點而言,本發明之具有嘧啶環構造之化合物較佳係下述一般式(a-2)或下述一般式(a-3)所示化合物。 From the viewpoints of electron injection, transport performance, hole blocking ability, and stability in a thin film state, the compound having a pyrimidine ring structure of the present invention is preferably the following general formula (a-2) or the following general formula ( a-3) The compound shown.
[化7]
(式中,A、B、Ar及R係與上述一般式(a-1)相同意義。) (In the formula, A, B, Ar and R have the same meaning as the above general formula (a-1).)
[化8]
(式中,A、B、Ar及R係與上述一般式(a-1)相同意義。) (In the formula, A, B, Ar and R have the same meaning as the above general formula (a-1).)
由電子注入、輸送性能、電洞阻止能力、薄膜狀態下之穩定性等觀點而言,本發明之具有嘧啶環構造之化合物較佳為上述一般式(a-2)所示者。 From the viewpoints of electron injection, transport performance, hole blocking ability, and stability in a thin film state, the compound having a pyrimidine ring structure of the present invention is preferably one represented by the above general formula (a-2).
亦即,本發明之具有嘧啶環構造之化合物最佳係由上述一般式(a-2)所示,Ar為取代或未取代之苯基、取代或未取代之蒽基、取代或未取代之菲基、取代或未取代之茀基或取代或未取代之螺二茀基,R為氫原子,L為未取代之苯基,Het為未取代之吡啶基、未取代之喹啉基或未取代之異喹啉基。 That is, the compound with a pyrimidine ring structure of the present invention is preferably represented by the above general formula (a-2), where Ar is substituted or unsubstituted phenyl, substituted or unsubstituted anthracenyl, substituted or unsubstituted Phenanthrene group, substituted or unsubstituted quinolyl or substituted or unsubstituted spirodipyryl, R is hydrogen atom, L is unsubstituted phenyl, Het is unsubstituted pyridyl, unsubstituted quinolinyl or unsubstituted Substituted isoquinolinyl.
本發明之具有嘧啶環構造之化合物係具有下述特性:(1)電子之注入特性佳、(2)電子之移動度大、(3)電洞阻止能力優異、(4)以薄膜狀態穩定存在、(5)耐熱性優異。又,本發明之有機EL元件具有下述特性:(1)發光效率及電力效率高、(2)發光初始電壓低、(3)實用驅動電壓低、(4)壽命長。 The compound with the pyrimidine ring structure of the present invention has the following characteristics: (1) good electron injection characteristics, (2) large electron mobility, (3) excellent hole blocking ability, (4) stable existence in a thin film state , (5) Excellent heat resistance. In addition, the organic EL device of the present invention has the following characteristics: (1) high luminous efficiency and power efficiency, (2) low light-emitting initial voltage, (3) low practical driving voltage, and (4) long life.
本發明之具有嘧啶環構造之化合物係電子之注入特性佳、電子之移動度大。藉此,具有使用該化合物作為電子注入材料及/或電子輸送材料所製作的電子注入層及/或電子輸送層的有機EL元件,係對發光層之電子輸送效率提升而發光效率提升,同時因驅動電壓降低而耐久性提升。 The compound with the pyrimidine ring structure of the present invention has good electron injection characteristics and high electron mobility. Thereby, an organic EL element having an electron injection layer and/or an electron transport layer made of the compound as an electron injection material and/or electron transport material improves the electron transport efficiency of the light emitting layer and the luminous efficiency is improved, while The driving voltage is reduced and the durability is improved.
本發明之具有嘧啶環構造之化合物係電洞阻止能力與電子輸送性優越,且於薄膜狀態下亦穩定,有封閉於發光層內所生成之激子的特徵。藉此,具有使用該化合物作為電洞阻止材料所製造的電洞阻止層的有機EL元件,係電洞與電子進行再結合之機率提升而抑制熱失活,故具有高發光效率,驅動電壓降低而改善電流耐性,故最大發光輝度提升。 The compound with the pyrimidine ring structure of the present invention has excellent hole blocking ability and electron transport properties, and is also stable in a thin film state, and has the characteristics of being enclosed in excitons generated in the light-emitting layer. As a result, the organic EL device with a hole blocking layer manufactured using the compound as a hole blocking material has an increased probability of recombination of holes and electrons to suppress thermal deactivation, so it has high luminous efficiency and reduced driving voltage As the current resistance is improved, the maximum luminous brightness is increased.
本發明之具有嘧啶環構造之化合物係電子輸送性優越、且能隙較廣。藉此,具有使用該化合物作為主體材料所製造之發光層的有機EL元件,係藉由使其載持所謂摻雜物的螢光發光體、磷光發光體及延遲螢光發光體而形成發光層,而降低驅動電壓並改善發光效率。 The compound having a pyrimidine ring structure of the present invention has excellent electron transport properties and a wide energy gap. Thereby, an organic EL device having a light-emitting layer manufactured using the compound as a host material forms a light-emitting layer by supporting a fluorescent light-emitting body, a phosphorescent light-emitting body, and a delayed fluorescent light-emitting body of so-called dopants , And reduce the driving voltage and improve the luminous efficiency.
因此,本發明之具有嘧啶環構造之化合物可用於作為有機EL元件之電子注入層、電子輸送層、電洞阻止層或發光層的材料,可改善習知有機EL元件之發光效率及驅動電壓、進而耐久性。 Therefore, the compound having a pyrimidine ring structure of the present invention can be used as a material for the electron injection layer, electron transport layer, hole blocking layer or light-emitting layer of organic EL devices, and can improve the luminous efficiency and driving voltage of conventional organic EL devices. And durability.
本發明之具有嘧啶環構造之化合物為新穎化合物,但此等化合物可根據其本身公知之方法進行合成(例如參照專利文獻5、非專利文獻6)。 The compounds having a pyrimidine ring structure of the present invention are novel compounds, but these compounds can be synthesized according to methods known per se (for example, refer to Patent Document 5 and Non-Patent Document 6).
本發明之具有嘧啶環構造之化合物的精製,可藉由下述者進行:管柱層析之精製;藉由矽膠、活性碳、活性白土等之吸附精製;藉由溶劑之再結晶或晶析法;昇華精製法等。 The purification of the compound with the pyrimidine ring structure of the present invention can be carried out by the following: purification by column chromatography; purification by adsorption of silica gel, activated carbon, activated clay, etc.; recrystallization or crystallization by solvent Method; sublimation refining method, etc.
本發明之上述一般式(a-1)所示具有嘧啶環構造之化合物中,較佳化合物之具體例如以下所示,但本發明並不限定於此等化合物。 Among the compounds having a pyrimidine ring structure represented by the general formula (a-1) of the present invention, specific examples of preferred compounds are shown below, but the present invention is not limited to these compounds.
[化9]
[化10]
[化11]
[化12]
[化13]
[化14]
[化15]
[化16]
[化17]
本發明之具有嘧啶環構造之化合物可使用作為有機EL元件之發光層、電子注入層、電子輸送層及電洞阻止層之構成材料。尤其因電子之移動度高,故為適合作為電子注入層或電子輸送層之構成材料的化合物。 The compound having a pyrimidine ring structure of the present invention can be used as a constituent material of the light-emitting layer, electron injection layer, electron transport layer, and hole blocking layer of an organic EL device. In particular, since the mobility of electrons is high, it is a compound suitable as a constituent material of the electron injection layer or the electron transport layer.
本發明之有機EL元件係具有一對電極、及挾持於其間之至少一層之有機層,其特徵在於使用本發明之具有嘧啶環構造之化合物作為至少一層之有機層的構成材料。作為上述有機層,可舉例如電洞注入層、電洞輸送層、電子阻止層、發光層、電洞阻止層、電子輸送層及電子注入層,本發明之具有嘧啶環構造之化合物可適合使用作為發光層、電洞阻止層、電子輸送層及電子注入層的構成材料。 The organic EL device of the present invention has a pair of electrodes and at least one organic layer sandwiched between them, and is characterized by using the compound having a pyrimidine ring structure of the present invention as a constituent material of the at least one organic layer. Examples of the organic layer include a hole injection layer, a hole transport layer, an electron blocking layer, a light emitting layer, a hole blocking layer, an electron transport layer, and an electron injection layer. The compound having a pyrimidine ring structure of the present invention can be suitably used As a constituent material of the light-emitting layer, hole blocking layer, electron transport layer, and electron injection layer.
作為本發明之有機EL元件之構造,可舉例如:於基板上依序具有陽極、電洞注入層、電洞輸送層、發光層、電子輸送層、電子注入層及陰極者;或於電洞輸送層與發光層之間具有電子阻止層者;於發光層與電子輸送層之間具有電洞阻止層者。此等多層構造中可以省略有機層等數層,或例如可作成為兼為電洞注入層與電洞輸送層之1層的構成、兼為電子注入層與電子輸送層之1層 的構成等。此外,可作成為積層2層以上之具有相同功能之有機層的構成,亦可作成為積層2層之電洞輸送層之構成、積層2層之發光層之構成、積層2層之電子輸送層之構成等。 As the structure of the organic EL device of the present invention, for example, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, and a cathode are sequentially provided on a substrate; Those with an electron blocking layer between the transport layer and the light-emitting layer; those with a hole blocking layer between the light-emitting layer and the electron transport layer. In these multi-layer structures, several layers such as organic layers can be omitted, or, for example, it can be used as a single layer of a hole injection layer and a hole transport layer, or a layer of an electron injection layer and an electron transport layer. The composition and so on. In addition, it can be used as a stack of two or more organic layers with the same function. It can also be used as a stack of two hole transport layers, two stacks of light-emitting layers, and two stacks of electron transport layers. The composition and so on.
作為本發明之有機EL元件的陽極,可使用ITO或如金般之功函數較大的電極材料。作為本發明之有機EL元件的電洞注入層,可使用以銅酞菁為代表之卟啉化合物、星爆型之三苯胺衍生物、具有於分子中具2個以上之三苯基胺構造或咔唑基構造且分別以單鍵或不含雜原子之2價基所連結之構造的芳基胺化合物、如六氰基氮雜三伸苯基般之受體性的雜環化合物、及塗佈型之高分子材料等。此等材料可藉由蒸鍍法、旋塗法及噴墨法等公知方法進行薄膜形成。 As the anode of the organic EL device of the present invention, ITO or an electrode material with a large work function like gold can be used. As the hole injection layer of the organic EL device of the present invention, a porphyrin compound represented by copper phthalocyanine, a starburst type triphenylamine derivative, a triphenylamine structure having two or more in the molecule, or Carbazolyl structure and arylamine compounds connected by single bonds or divalent groups without heteroatoms, acceptor heterocyclic compounds such as hexacyanoazatriphenylene, and coatings Cloth-type polymer materials, etc. These materials can be formed into thin films by well-known methods such as vapor deposition, spin coating, and inkjet.
作為本發明之有機EL元件的電洞輸送層,可使用N,N'-二苯基-N,N'-二(間甲苯基)-聯苯胺(以下簡稱為TPD)或N,N'-二苯基-N,N'-二(α-萘基)-聯苯胺(以下簡稱為NPD)、N,N,N',N'-四聯苯基聯苯胺等聯苯胺衍生物,1,1-雙[(二-4-甲苯基胺基)苯基]環己烷(以下簡稱為TAPC)、及具有於分子中具2個以上的三苯基胺構造或咔唑基構造且分別以單鍵或不含有雜原子之2價基所連結之構造的芳基胺化合物等。此等可單獨成膜,亦可與其它材料混合而成膜為單層,或亦可作成為將上述複數材料分別單獨成膜之層彼此積層的積層構造、將上述複數材料混合並成膜之層彼此積層的積層構造、或將上述複數材料分別單獨成膜之層及混合而成膜之層進行積層的積層構造。又,作為電洞之注入、輸送層,可使用聚(3,4-乙烯二氧噻吩)(以下簡稱為PEDOT)/聚(苯乙烯磺酸)(以下簡稱為PSS)等塗佈型之高分子材料。此等材料可使用蒸鍍法、旋塗法或噴墨法 等公知方法進行薄膜形成。 As the hole transport layer of the organic EL device of the present invention, N,N'-diphenyl-N,N'-bis(m-tolyl)-benzidine (hereinafter referred to as TPD) or N,N'- Diphenyl-N,N'-bis(α-naphthyl)-benzidine (hereinafter referred to as NPD), N,N,N',N'-tetraphenylbenzidine and other benzidine derivatives, 1, 1-bis[(Di-4-tolylamino)phenyl]cyclohexane (hereinafter referred to as TAPC), and having two or more triphenylamine structures or carbazolyl structures in the molecule and each with Single bond or arylamine compound of a structure connected by a divalent group not containing a heteroatom, etc. These can be formed into a film alone, or mixed with other materials to form a single layer, or can be used as a layered structure in which the above-mentioned plural materials are separately formed into films, and the above-mentioned plural materials are mixed and formed into a film. A layered structure in which layers are stacked on top of each other, or a layer in which the above-mentioned plural materials are separately formed into a film and a layer in which a film is formed by mixing them. In addition, as the hole injection and transport layer, poly(3,4-ethylenedioxythiophene) (hereinafter referred to as PEDOT)/poly(styrene sulfonic acid) (hereinafter referred to as PSS) and other coating types can be used. Molecular materials. These materials can use evaporation, spin coating or inkjet The thin film is formed by well-known methods.
又,作為電洞注入層或電洞輸送層,可使用:對於該層所通常使用之材料進一步使三溴苯胺六氯銻或軸烯衍生物(例如參照專利文獻7)經P摻雜者;及於其部分構造具有TPD等聯苯胺衍生物之構造的高分子化合物等。 In addition, as the hole injection layer or the hole transport layer, it is possible to use: a material commonly used for this layer is further P-doped with tribromoaniline hexachloroantimony or an axene derivative (for example, refer to Patent Document 7); And a part of the structure has a polymer compound such as TPD and other benzidine derivatives.
作為本發明之有機EL元件之電子阻止層,可使用:4,4',4"-三(N-咔唑基)三苯基胺(以下簡稱為TCTA)、9,9-雙[4-(咔唑-9-基)苯基]茀、1,3-雙(咔唑-9-基)苯(以下簡稱為mCP)、2,2-雙(4-咔唑-9-基苯基)金剛烷(以下簡稱為Ad-Cz)等咔唑衍生物,以9-[4-(咔唑-9-基)苯基]-9-[4-(三苯基矽烷基)苯基]-9H-茀為代表的具有三苯基矽烷基與三芳基胺構造之化合物等之具有電子阻止作用的化合物。此等可單獨成膜,亦可與其它材料混合而成膜為單層,或亦可作成為將上述複數材料分別單獨成膜之層彼此積層的積層構造、將上述複數材料混合並成膜之層彼此積層的積層構造、或將上述複數材料分別單獨成膜之層及混合而成膜之層進行積層的積層構造。此等材料可使用蒸鍍法、旋塗法或噴墨法等公知方法進行薄膜形成。 As the electron blocking layer of the organic EL device of the present invention, 4,4',4"-tris(N-carbazolyl)triphenylamine (hereinafter referred to as TCTA), 9,9-bis[4- (Carbazol-9-yl)phenyl) pyrene, 1,3-bis(carbazol-9-yl)benzene (hereinafter referred to as mCP), 2,2-bis(4-carbazol-9-ylphenyl) ) Carbazole derivatives such as adamantane (hereinafter referred to as Ad-Cz), with 9-[4-(carbazol-9-yl)phenyl]-9-[4-(triphenylsilyl)phenyl] -9H-茀 is represented by compounds with triphenylsilyl and triarylamine structures and other compounds with electron blocking effect. These can be formed into films alone or mixed with other materials to form a single layer, or It can also be made into a layered structure in which layers of the above-mentioned plural materials are separately formed into films, a layered structure in which layers of the above-mentioned plural materials are mixed and formed into films are stacked on each other, or a layer in which the above-mentioned plural materials are separately formed into films and mixed together A layered structure in which the film-forming layers are stacked. These materials can be formed into thin films using well-known methods such as vapor deposition, spin coating, or inkjet methods.
作為本發明之有機EL元件的發光層,除了本發明之具有嘧啶環構造之化合物以外,尚可使用以Alq3為首的喹啉酚衍生物之金屬錯合物,及各種金屬錯合物、蒽衍生物、雙苯乙烯基苯衍生物、芘衍生物、唑衍生物、聚對伸苯基伸乙烯基衍生物等。又,發光層可由主體材料與摻雜劑材料構成,較佳使用蒽衍生物作為主體材料,但除了以本發明之具有嘧啶環構造之化合物為首的上述發光材料之外,亦可使用具有吲哚環作為縮合環之部分構造之雜環化 合物、具有咔唑環作為縮合環之部分構造之雜環化合物、咔唑衍生物、噻唑衍生物、苯并咪唑衍生物、聚二烷基茀衍生物等。又,作為摻雜劑材料,可使用喹吖酮、香豆素、紅螢烯、苝及此等之衍生物、苯并吡喃衍生物、若丹明衍生物、胺基苯乙烯基衍生物等。此等可單獨成膜,亦可與其它材料混合而成膜為單層,或亦可作成為將上述複數材料分別單獨成膜之層彼此積層的積層構造、將上述複數材料混合並成膜之層彼此積層的積層構造、或將上述複數材料分別單獨成膜之層及混合而成膜之層進行積層的積層構造。此等材料可使用蒸鍍法、旋塗法或噴墨法等公知方法進行薄膜形成。 As the light-emitting layer of the organic EL device of the present invention, in addition to the compound having a pyrimidine ring structure of the present invention, metal complexes of quinolinol derivatives such as Alq 3 , and various metal complexes, anthracene Derivatives, bisstyrylbenzene derivatives, pyrene derivatives, Azole derivatives, polyparaphenylene vinylene derivatives, etc. In addition, the light-emitting layer may be composed of a host material and a dopant material. Anthracene derivatives are preferably used as the host material. However, in addition to the above-mentioned light-emitting materials including the compound having a pyrimidine ring structure of the present invention, an indole Heterocyclic compounds with a ring as a part of the condensed ring, heterocyclic compounds with a carbazole ring as a part of the condensed ring, carbazole derivatives, thiazole derivatives, benzimidazole derivatives, polydialkyl phosphonium derivatives, etc. . In addition, as dopant materials, quinacridone, coumarin, fluorene, perylene and their derivatives, benzopyran derivatives, rhodamine derivatives, aminostyryl derivatives can be used Wait. These can be formed into a film alone, or mixed with other materials to form a single layer, or can be used as a layered structure in which the above-mentioned plural materials are separately formed into films, and the above-mentioned plural materials are mixed and formed into a film. A layered structure in which layers are stacked on top of each other, or a layer in which the above-mentioned plural materials are separately formed into a film and a layer in which a film is formed by mixing them. These materials can be formed into thin films using well-known methods such as vapor deposition, spin coating, or inkjet methods.
再者,亦可使用磷光發光體作為發光材料。作為磷光發光體,可使用銥或鉑等金屬錯合物之磷光發光體。使用Ir(ppy)3等綠色之磷光發光體、FIrpic、FIr6等藍色之磷光發光體、Btp2Ir(acac)等紅色之磷光發光體等。作為此時之主體材料,電洞注入、輸送性的主體材料可使用4,4'-二(N-咔唑基)聯苯(以下簡稱為CBP)、TCTA、mCP等咔唑衍生物等以外,尚可使用本發明之具有嘧啶環構造之化合物。又,作為電子輸送性之主體材料可使用對-雙(三苯基矽烷基)苯(以下簡稱為UGH2)或2,2',2"-(1,3,5-伸苯基)-參(1-苯基-1H-苯并咪唑)(以下簡稱為TPBI)等,可製作高性能的有機EL元件。 Furthermore, phosphorescent emitters can also be used as luminescent materials. As the phosphorescent emitter, a phosphorescent emitter of a metal complex such as iridium or platinum can be used. Green phosphorescent emitters such as Ir(ppy) 3 , blue phosphorescent emitters such as FIrpic and FIr6, red phosphorescent emitters such as Btp 2 Ir(acac), etc. are used. As the host material at this time, the host material for hole injection and transport can use 4,4'-bis(N-carbazolyl)biphenyl (hereinafter referred to as CBP), TCTA, mCP and other carbazole derivatives. , The compound with pyrimidine ring structure of the present invention can still be used. In addition, as a host material for electron transport properties, p-bis(triphenylsilyl)benzene (hereinafter referred to as UGH2) or 2,2',2"-(1,3,5-phenylene)-reference can be used (1-Phenyl-1H-benzimidazole) (hereinafter referred to as TPBI), etc., can produce high-performance organic EL devices.
磷光性之發光材料對於主體材料的摻雜,係為了避免濃度猝滅,較佳係依相對於發光層整體為1~30重量%之範圍,藉由共蒸鍍進行。 The doping of the phosphorescent light-emitting material to the host material is to avoid concentration quenching, and is preferably performed by co-evaporation in a range of 1 to 30% by weight relative to the entire light-emitting layer.
又,作為發光材料亦可使用PIC-TRZ、CC2TA、PXZ-TRZ、4CzIPN等之CDCB衍生物等放射出延遲螢光的材料(例 如參照非專利文獻3)。此等材料可使用蒸鍍法、旋塗法或噴墨法等公知方法進行薄膜形成。 In addition, as the luminescent material, CDCB derivatives such as PIC-TRZ, CC2TA, PXZ-TRZ, 4CzIPN, etc. can also be used to emit delayed fluorescence (e.g. For example, refer to Non-Patent Document 3). These materials can be formed into thin films using well-known methods such as vapor deposition, spin coating, or inkjet methods.
作為本發明之有機EL元件的電洞阻止層,除了本發明之具有嘧啶環構造之化合物以外,尚可使用如浴銅靈(以下簡稱為BCP)等啡啉衍生物、BAlq等喹啉酚衍生物之金屬錯合物、各種稀土族錯合物、唑衍生物、三唑衍生物、三衍生物等具有電洞阻止作用的化合物。此等材料亦可兼為電子輸送層之材料。此等可單獨成膜,亦可與其它材料混合而成膜為單層,或亦可作成為將上述複數材料分別單獨成膜之層彼此積層的積層構造、將上述複數材料混合並成膜之層彼此積層的積層構造、或將上述複數材料分別單獨成膜之層及混合而成膜之層進行積層的積層構造。此等材料可使用蒸鍍法、旋塗法或噴墨法等公知方法進行薄膜形成。 As the hole blocking layer of the organic EL device of the present invention, in addition to the compound having a pyrimidine ring structure of the present invention, phenanthroline derivatives such as Yutongling (hereinafter referred to as BCP) and quinolinol derivatives such as BAlq can be used. Metal complexes, various rare earth complexes, Azole derivatives, triazole derivatives, three Derivatives and other compounds with hole blocking effect. These materials can also serve as materials for the electron transport layer. These can be formed into a film alone, or mixed with other materials to form a single layer, or can be used as a layered structure in which the above-mentioned plural materials are separately formed into films, and the above-mentioned plural materials are mixed and formed into a film. A layered structure in which layers are stacked on top of each other, or a layer in which the above-mentioned plural materials are separately formed into a film and a layer in which a film is formed by mixing them. These materials can be formed into thin films using well-known methods such as vapor deposition, spin coating, or inkjet methods.
作為本發明之有機EL元件的電子輸送層,除了本發明之具有嘧啶環構造之化合物以外,尚可使用以Alq3、BAlq為首之喹啉酚衍生物的金屬錯合物、各種金屬錯合物、三唑衍生物、三衍生物、二唑衍生物、吡啶衍生物、苯并咪唑衍生物、噻二唑衍生物、蒽衍生物、碳化二亞胺衍生物、喹啉衍生物、吡啶并吲哚衍生物、啡啉衍生物、矽咯衍生物等。此等可單獨成膜,亦可與其它材料混合而成膜為單層,或亦可作成為將上述複數材料分別單獨成膜之層彼此積層的積層構造、將上述複數材料混合並成膜之層彼此積層的積層構造、或將上述複數材料分別單獨成膜之層及混合而成膜之層進行積層的積層構造。此等材料可使用蒸鍍法、旋塗法或噴墨法等公知方法進行薄膜形成。 As the electron transport layer of the organic EL device of the present invention, in addition to the compound having a pyrimidine ring structure of the present invention, metal complexes of quinolinol derivatives such as Alq 3 and BAlq, and various metal complexes can be used , Triazole derivatives, three derivative, Diazole derivatives, pyridine derivatives, benzimidazole derivatives, thiadiazole derivatives, anthracene derivatives, carbodiimide derivatives, quine Phytoline derivatives, pyridoindole derivatives, phenanthroline derivatives, silica derivatives, etc. These can be formed into a film alone, or mixed with other materials to form a single layer, or can be used as a layered structure in which the above-mentioned plural materials are separately formed into films, and the above-mentioned plural materials are mixed and formed into a film. A layered structure in which layers are stacked on top of each other, or a layer in which the above-mentioned plural materials are separately formed into a film and a layer in which a film is formed by mixing them. These materials can be formed into thin films using well-known methods such as vapor deposition, spin coating, or inkjet methods.
作為本發明之有機EL元件的電子注入層,除了本發 明之具有嘧啶環構造之化合物以外,尚可使用氟化鋰、氟化銫等鹼金屬鹽、氟化鎂等鹼土族金屬鹽、鋰喹啉酚等喹啉酚衍生物的金屬錯合物、氧化鋁等金屬氧化物、或鐿(Yb)、釤(Sm)、鈣(Ca)、鍶(Sr)、銫(Cs)等金屬等,但於電子輸送層與陰極的較佳選擇之中,可省略電子注入層。 As the electron injection layer of the organic EL element of the present invention, in addition to the present invention In addition to compounds with a pyrimidine ring structure, metal complexes of alkali metal salts such as lithium fluoride and cesium fluoride, alkaline earth metal salts such as magnesium fluoride, and quinolinol derivatives such as lithium quinolol can be used. Metal oxides such as aluminum, or metals such as ytterbium (Yb), samarium (Sm), calcium (Ca), strontium (Sr), cesium (Cs), etc., but among the better choices of electron transport layer and cathode, The electron injection layer is omitted.
進而,於電子注入層或電子輸送層之中,可使用對於該層通常使用之材料進一步N摻雜了銫等金屬者。 Furthermore, in the electron injection layer or the electron transport layer, a material generally used for this layer may be further N-doped with metals such as cesium.
作為本發明之有機EL元件的陰極,可使用鋁般之功函數低之電極材料、或鎂銀合金、鎂銦合金、鋁鎂合金般之功函數更低的合金作為電極材料。 As the cathode of the organic EL device of the present invention, an electrode material with a low work function like aluminum, or an alloy with a lower work function like magnesium-silver alloy, magnesium indium alloy, and aluminum-magnesium alloy can be used as the electrode material.
本發明之有機EL元件由於使用電子之注入、輸送性能、薄膜穩定性或耐久性優越的本發明之具有嘧啶環構造之化合物作為構成材料,故相較於習知之有機EL元件,其可提升由電子輸送層對發光層的電子輸送效率而提升發光效率,同時可降低驅動電壓而提升耐久性,可實現高效率、低驅動電壓、長壽命。 Since the organic EL element of the present invention uses the compound having a pyrimidine ring structure of the present invention, which is superior in electron injection and transport performance, film stability, or durability, as a constituent material, it can be improved compared to conventional organic EL elements. The electron transport efficiency of the electron transport layer to the light-emitting layer improves the luminous efficiency, and at the same time can reduce the driving voltage and improve the durability, and can achieve high efficiency, low driving voltage and long life.
[實施例] [Example]
以下藉由實施例具體說明本發明之實施形態,但本發明係在不脫離其要旨之前提下,並不限定於以下實施例。 Hereinafter, the embodiments of the present invention will be described in detail with examples, but the present invention is mentioned without departing from the gist and is not limited to the following examples.
[實施例1] [Example 1]
<2-{4-(菲-9-基)-苯基}-4,6-雙-{4-(吡啶-3-基)-苯基}-嘧啶(化合物-5)之合成> <Synthesis of 2-{4-(phenanthrene-9-yl)-phenyl}-4,6-bis-{4-(pyridin-3-yl)-phenyl}-pyrimidine (compound-5)>
於反應容器內填裝4,6-雙-(4-氯-苯基)-2-{4-(菲-9-基)-苯基}-嘧啶:11.0g、3-吡啶基硼酸:5.9g、參(二亞苄基丙酮)二鈀(0):0.9g、 三環己基膦:1.1g、碳酸鉀:8.2g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,於系統內加入H2O,將析出之固體過濾獲得粗製生成物。將所得粗製生成物藉由單氯苯溶媒進行再結晶精製,獲得2-{4-(菲-9-基)-苯基}-4,6-雙-{4-(吡啶-3-基)-苯基}-嘧啶(化合物-5)之白色粉體:7.9g(產率62%)。 Fill the reaction vessel with 4,6-bis-(4-chloro-phenyl)-2-{4-(phenanthrene-9-yl)-phenyl}-pyrimidine: 11.0g, 3-pyridylboronic acid: 5.9 g. Ginseng (dibenzylideneacetone)dipalladium (0): 0.9g, tricyclohexylphosphine: 1.1g, potassium carbonate: 8.2g, in 1,4-di Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, H 2 O was added to the system, and the precipitated solid was filtered to obtain a crude product. The obtained crude product was recrystallized and purified with a monochlorobenzene solvent to obtain 2-{4-(phenanthrene-9-yl)-phenyl}-4,6-bis-{4-(pyridin-3-yl) -Phenyl}-pyrimidine (compound-5) white powder: 7.9g (62% yield).
[化18]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下30個的氫信號。 The following 30 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=9.00(2H)、8.93(2H)、8.84(1H)、8.78(1H)、8.69(2H)、8.51(4H)、8.18(1H)、8.08-7.94(4H)、7.88-7.55(11H)、7.47(1H)、7.45(1H) δ(ppm)=9.00(2H), 8.93(2H), 8.84(1H), 8.78(1H), 8.69(2H), 8.51(4H), 8.18(1H), 8.08-7.94(4H), 7.88-7.55 (11H), 7.47(1H), 7.45(1H)
[實施例2] [Example 2]
<2-(10-苯基-蒽-9-基)-4,6-雙-{4-(吡啶-3-基)-苯基}-嘧啶(化合物-12)之合成> <Synthesis of 2-(10-phenyl-anthracene-9-yl)-4,6-bis-{4-(pyridin-3-yl)-phenyl}-pyrimidine (compound-12)>
於反應容器內填裝4,6-雙-(4-氯-苯基)-2-(10-苯基-蒽-9-基)-嘧啶:5.2g、3-吡啶基硼酸:2.8g、參(二亞苄基丙酮)二鈀(0):0.4g、三環己基膦:0.5g、碳酸鉀:3.9g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,於系統內加入H2O,將析出之固體過濾獲得粗製生成物。將所得粗製生成物藉由單氯苯溶媒進行再結 晶精製,獲得2-(10-苯基-蒽-9-基)-4,6-雙-{4-(吡啶-3-基)-苯基}-嘧啶(化合物-12)之白色粉體:1.5g(產率25%)。 Fill the reaction vessel with 4,6-bis-(4-chloro-phenyl)-2-(10-phenyl-anthracene-9-yl)-pyrimidine: 5.2g, 3-pyridylboronic acid: 2.8g, Ginseng (dibenzylideneacetone)dipalladium (0): 0.4g, tricyclohexylphosphine: 0.5g, potassium carbonate: 3.9g, in 1,4-di Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, H 2 O was added to the system, and the precipitated solid was filtered to obtain a crude product. The obtained crude product was recrystallized and purified with a monochlorobenzene solvent to obtain 2-(10-phenyl-anthracene-9-yl)-4,6-bis-{4-(pyridin-3-yl)-benzene White powder of yl}-pyrimidine (Compound-12): 1.5 g (yield 25%).
[化19]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下30個的氫信號。 The following 30 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=8.95(2H)、8.66(2H)、8.44(4H)、8.40(1H)、7.98(2H)、7.85(2H)、7.79(4H)、7.76(2H)、7.69-7.57(3H)、7.52(2H)、7.48-7.34(6H) δ(ppm)=8.95(2H), 8.66(2H), 8.44(4H), 8.40(1H), 7.98(2H), 7.85(2H), 7.79(4H), 7.76(2H), 7.69-7.57(3H) ), 7.52(2H), 7.48-7.34(6H)
[實施例3] [Example 3]
<4,6-雙-{4-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-19)之合成> <4,6-Bis-{4-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2-yl)-pyrimidine (Compound-19) >
於反應容器內填裝4,6-雙-(4-氯-苯基)-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶:8.0g、3-吡啶基硼酸:3.8g、參(二亞苄基丙酮)二鈀(0):0.6g、三環己基膦:0.7g、碳酸鉀:5.4g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,於系統內加入H2O,將析出之固體過濾獲得粗製生成物。將所得粗製生成物藉由單氯苯溶媒進行再結晶精製,獲得4,6-雙-{4-(吡啶-3-基)-苯基}-2-(9,9’-螺雙[9H]茀-2-基)-嘧啶(化合物-19)之白色粉體:3.0g(產率33%)。 Fill the reaction vessel with 4,6-bis-(4-chloro-phenyl)-2-(9,9'-spirobis[9H]茀-2-yl)-pyrimidine: 8.0g, 3-pyridyl Boric acid: 3.8g, ginseng (dibenzylideneacetone) dipalladium (0): 0.6g, tricyclohexylphosphine: 0.7g, potassium carbonate: 5.4g, in 1,4-di Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, H 2 O was added to the system, and the precipitated solid was filtered to obtain a crude product. The obtained crude product was recrystallized and refined with a monochlorobenzene solvent to obtain 4,6-bis-{4-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H ] White powder of 茀-2-yl)-pyrimidine (Compound-19): 3.0 g (yield 33%).
[化20]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下32個的氫信號。 The following 32 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=8.95(2H)、8.87(1H)、8.66(2H)、8.30(4H)、8.08(1H)、8.06(1H)、8.01-7.90(6H)、7.76(4H)、7.46-7.38(5H)、7.17(2H)、7.14(1H)、6.83(2H)、6.75(1H) δ(ppm)=8.95(2H), 8.87(1H), 8.66(2H), 8.30(4H), 8.08(1H), 8.06(1H), 8.01-7.90(6H), 7.76(4H), 7.46-7.38 (5H), 7.17(2H), 7.14(1H), 6.83(2H), 6.75(1H)
[實施例4] [Example 4]
<2-(菲-2-基)-4-{3-(吡啶-3-基)-苯基}-6-{4-(吡啶-3-基)-苯基}-嘧啶(化合物-27)之合成> <2-(phenanthrene-2-yl)-4-{3-(pyridin-3-yl)-phenyl}-6-{4-(pyridin-3-yl)-phenyl}-pyrimidine (compound-27 ) Synthesis>
於反應容器內填裝4-(4-氯-苯基)-2-(菲-2-基)-6-{3-(吡啶-3-基)-苯基}-嘧啶:8.9g、3-吡啶基硼酸:2.3g、參(二亞苄基丙酮)二鈀(0):0.5g、三環己基膦:1.0g、磷酸三鉀:7.3g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,藉分液操作對有機層進行分液萃取及減壓下濃縮。將所得粗製生成物藉由管柱層析法(載體:矽膠,洗提液:二氯甲烷/醋酸乙酯)進行精製,得到2-(菲-2-基)-4-{3-(吡啶-3-基)-苯基}-6-{4-(吡啶-3-基)-苯基}-嘧啶(化合物-27)之白色粉體:6.0g(產率63%)。 Fill the reaction vessel with 4-(4-chloro-phenyl)-2-(phenanthrene-2-yl)-6-{3-(pyridin-3-yl)-phenyl}-pyrimidine: 8.9g, 3 -Pyridyl boronic acid: 2.3g, ginseng (dibenzylideneacetone) dipalladium (0): 0.5g, tricyclohexylphosphine: 1.0g, tripotassium phosphate: 7.3g, in 1,4-di Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, the organic layer was separated and extracted and concentrated under reduced pressure by liquid separation operation. The obtained crude product was purified by column chromatography (carrier: silica gel, eluent: dichloromethane/ethyl acetate) to obtain 2-(phenanthrene-2-yl)-4-{3-(pyridine) White powder of -3-yl)-phenyl}-6-{4-(pyridin-3-yl)-phenyl}-pyrimidine (compound-27): 6.0 g (63% yield).
[化21]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下26個的氫信號。 The following 26 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=9.29(1H)、9.05(1H)、9.01(2H)、8.87(1H)、8.80(1H)、8.70(2H)、8.53(1H)、8.51(2H)、8.39(1H)、8.15(1H)、8.10-7.93(4H)、7.90-7.62(7H)、7.48(2H) δ(ppm)=9.29(1H), 9.05(1H), 9.01(2H), 8.87(1H), 8.80(1H), 8.70(2H), 8.53(1H), 8.51(2H), 8.39(1H), 8.15(1H), 8.10-7.93(4H), 7.90-7.62(7H), 7.48(2H)
[實施例5] [Example 5]
<4-{3-(吡啶-3-基)-苯基}-6-{4-(吡啶-3-基)-苯基}-2-(9,9’-螺雙[9H]茀-2-基)-嘧啶(化合物-31)之合成> <4-{3-(pyridin-3-yl)-phenyl}-6-{4-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀- Synthesis of 2-yl)-pyrimidine (Compound-31)>
於反應容器內填裝4-(4-氯-苯基)-6-{3-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶:11.4g、3-吡啶基硼酸:2.3g、參(二亞苄基丙酮)二鈀(0):0.5g、三環己基膦:0.5g、磷酸三鉀:7.4g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,藉分液操作對有機層進行分液萃取及減壓下濃縮。將所得粗製生成物藉由管柱層析法(載體:矽膠,洗提液:二氯甲烷/醋酸乙酯)進行精製,得到4-{3-(吡啶-3-基)-苯基}-6-{4-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-31)之白色粉體:9.2g(產率76%)。 Fill the reaction vessel with 4-(4-chloro-phenyl)-6-{3-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2 -Yl)-pyrimidine: 11.4g, 3-pyridylboronic acid: 2.3g, ginseng (dibenzylideneacetone)dipalladium (0): 0.5g, tricyclohexylphosphine: 0.5g, tripotassium phosphate: 7.4g, On 1,4-Tues Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, the organic layer was separated and extracted and concentrated under reduced pressure by liquid separation operation. The obtained crude product was purified by column chromatography (carrier: silica gel, eluent: dichloromethane/ethyl acetate) to obtain 4-{3-(pyridin-3-yl)-phenyl}- 6-{4-(Pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2-yl)-pyrimidine (Compound-31) white powder: 9.2g (Yield 76%).
[化22]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下32個的氫信號。 The following 32 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=8.93(2H)、8.82(1H)、8.69(1H)、8.65(1H)、8.39(1H)、8.29(2H)、8.18(1H)、8.05(1H)、8.03(1H)、7.99(1H)、7.98-7.88(5H)、7.74(3H)、7.65(1H)、7.48-7.35(5H)、7.13(3H)、6.81(2H)、6.76(1H) δ(ppm)=8.93(2H), 8.82(1H), 8.69(1H), 8.65(1H), 8.39(1H), 8.29(2H), 8.18(1H), 8.05(1H), 8.03(1H), 7.99(1H), 7.98-7.88(5H), 7.74(3H), 7.65(1H), 7.48-7.35(5H), 7.13(3H), 6.81(2H), 6.76(1H)
[實施例6] [Example 6]
<2-{4-(萘-1-基)-苯基}-4-{4-(吡啶-3-基)-苯基}-6-{4-(喹啉-8-基)-苯基}-嘧啶(化合物-36)之合成> <2-{4-(Naphthalene-1-yl)-phenyl}-4-{4-(pyridin-3-yl)-phenyl}-6-{4-(quinolin-8-yl)-benzene Synthesis of yl)-pyrimidine (Compound-36)>
於反應容器內填裝4-(4-氯-苯基)-6-{4-(吡啶-3-基)-苯基}-2-{4-(萘-1-基)-苯基}-嘧啶:8.0g、8-喹啉基硼酸:2.8g、參(二亞苄基丙酮)二鈀(0):0.4g、三環己基膦:0.4g、磷酸三鉀:6.2g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,於系統內加入甲醇,將析出之固體過濾獲得粗製生成物。將所得粗製生成物藉由單氯苯溶媒進行再結晶精製,獲得2-{4-(萘-1-基)-苯基}-4-{4-(吡啶-3-基)-苯基}-6-{4-(喹啉-8-基)-苯基}-嘧啶(化合物-36)之白色粉體:7.0g(產率74%)。 Fill the reaction vessel with 4-(4-chloro-phenyl)-6-{4-(pyridin-3-yl)-phenyl}-2-{4-(naphthalene-1-yl)-phenyl} -Pyrimidine: 8.0g, 8-quinolinylboronic acid: 2.8g, ginseng (dibenzylideneacetone) dipalladium (0): 0.4g, tricyclohexylphosphine: 0.4g, tripotassium phosphate: 6.2g, in 1 ,4-two Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, methanol was added to the system, and the precipitated solid was filtered to obtain a crude product. The obtained crude product was recrystallized and refined with a monochlorobenzene solvent to obtain 2-{4-(naphthalene-1-yl)-phenyl}-4-{4-(pyridin-3-yl)-phenyl} White powder of 6-{4-(quinolin-8-yl)-phenyl}-pyrimidine (Compound-36): 7.0 g (yield 74%).
[化23]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下30個的氫信號。 The following 30 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=9.03(1H)、9.00(1H)、8.93(2H)、8.69(1H)、8.51(4H)、8.29(1H)、8.20(1H)、8.09-7.78(10H)、7.74(2H)、7.70(1H)、7.65-7.41(6H) δ(ppm)=9.03(1H), 9.00(1H), 8.93(2H), 8.69(1H), 8.51(4H), 8.29(1H), 8.20(1H), 8.09-7.78(10H), 7.74(2H) ), 7.70(1H), 7.65-7.41(6H)
[實施例7] [Example 7]
<4,6-雙-{4-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-84)之合成> <4,6-Bis-{4-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2-yl)-pyrimidine (Compound-84) >
於反應容器內填裝4,6-雙-(4-氯-苯基)-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶:8.2g、3-吡啶基硼酸:3.9g、參(二亞苄基丙酮)二鈀(0):0.6g、三環己基膦:0.7g、碳酸鉀:5.5g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,於系統內加入H2O,將析出之固體過濾獲得粗製生成物。將所得粗製生成物藉由單氯苯溶媒進行再結晶精製,獲得4,6-雙-{4-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-84)之白色粉體:2.6g(產率28%)。 Fill the reaction vessel with 4,6-bis-(4-chloro-phenyl)-2-(9,9'-spirobis[9H]茀-2-yl)-pyrimidine: 8.2g, 3-pyridyl Boric acid: 3.9g, ginseng (dibenzylideneacetone) dipalladium (0): 0.6g, tricyclohexylphosphine: 0.7g, potassium carbonate: 5.5g, in 1,4-di Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, H 2 O was added to the system, and the precipitated solid was filtered to obtain a crude product. The obtained crude product was recrystallized and refined with a monochlorobenzene solvent to obtain 4,6-bis-{4-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H ] White powder of 茀-2-yl)-pyrimidine (Compound-84): 2.6 g (yield 28%).
[化24]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下32個的氫信號。 The following 32 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=8.97(2H)、8.66(2H)、8.49(4H)、8.34(1H)、7.99(2H)、7.88(3H)、7.82(4H)、7.79(1H)、7.43(4H)、7.39(1H)、7.16(2H)、7.10(2H)、6.90(2H)、6.87(1H)、6.76(1H) δ(ppm)=8.97(2H), 8.66(2H), 8.49(4H), 8.34(1H), 7.99(2H), 7.88(3H), 7.82(4H), 7.79(1H), 7.43(4H), 7.39(1H), 7.16(2H), 7.10(2H), 6.90(2H), 6.87(1H), 6.76(1H)
[實施例8] [Example 8]
<4,6-雙-{4-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-3-基)-嘧啶(化合物-85)之合成> <4,6-Bis-{4-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-3-yl)-pyrimidine (Compound-85) >
於反應容器內填裝4,6-雙-(4-氯-苯基)-2-(9,9'-螺雙[9H]茀-3-基)-嘧啶:7.0g、3-吡啶基硼酸:3.3g、參(二亞苄基丙酮)二鈀(0):0.3g、三環己基膦:0.3g、磷酸三鉀:4.8g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,藉分液操作對有機層進行分液萃取及減壓下濃縮。將所得粗製生成物藉由管柱層析法(載體:矽膠,洗提液:二氯甲烷/醋酸乙酯)進行精製,得到4,6-雙-{4-(吡啶-3-基)-苯基}-2-(9,9’-螺雙[9H]茀-3-基)-嘧啶(化合物-85)之白色粉體:2.6g(產率28%)。 Fill the reaction vessel with 4,6-bis-(4-chloro-phenyl)-2-(9,9'-spirobis[9H]茀-3-yl)-pyrimidine: 7.0g, 3-pyridyl Boric acid: 3.3g, ginseng (dibenzylideneacetone) dipalladium (0): 0.3g, tricyclohexylphosphine: 0.3g, tripotassium phosphate: 4.8g, in 1,4-di Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, the organic layer was separated and extracted and concentrated under reduced pressure by liquid separation operation. The obtained crude product was purified by column chromatography (carrier: silica gel, eluent: dichloromethane/ethyl acetate) to obtain 4,6-bis-{4-(pyridin-3-yl)- White powder of phenyl}-2-(9,9'-spirobis[9H]茀-3-yl)-pyrimidine (Compound-85): 2.6 g (yield 28%).
[化25]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下34個的氫信號。 The following 34 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=9.11(1H)、9.00(2H)、8.70(2H)、8.68(1H)、8.48(4H)、8.17(1H)、8.03(3H)、7.85(4H)、7.62(1H)、7.47(4H)、7.38-7.21(11H) δ(ppm)=9.11(1H), 9.00(2H), 8.70(2H), 8.68(1H), 8.48(4H), 8.17(1H), 8.03(3H), 7.85(4H), 7.62(1H), 7.47(4H), 7.38-7.21(11H)
[實施例9] [Example 9]
<4-{4-(異喹啉-4-基)-苯基}-6-{3-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-86)之合成> <4-{4-(isoquinolin-4-yl)-phenyl}-6-{3-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H] Synthesis of pyrimidine-2-yl)-pyrimidine (compound-86)>
於反應容器內填裝4-(4-氯-苯基)-6-{3-(吡啶-3-基)-苯基}-2-(9,9’-螺雙[9H]茀-2-基)-嘧啶:11.3g、4-異喹啉基硼酸:3.6g、參(二亞苄基丙酮)二鈀(0):0.5g、三環己基膦:0.5g、磷酸三鉀:7.3g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,藉分液操作對有機層進行分液萃取及減壓下濃縮。將所得粗製生成物藉由管柱層析法(載體:矽膠,洗提液:二氯甲烷/醋酸乙酯)進行精製,得到4-{4-(異喹啉-4-基)-苯基}-6-{3-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-86)之白色粉體:8.1g(產率63%)。 Fill the reaction vessel with 4-(4-chloro-phenyl)-6-{3-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2 -Yl)-pyrimidine: 11.3g, 4-isoquinolinylboronic acid: 3.6g, ginseng (dibenzylideneacetone)dipalladium (0): 0.5g, tricyclohexylphosphine: 0.5g, tripotassium phosphate: 7.3 g, at 1,4-Tues Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, the organic layer was separated and extracted and concentrated under reduced pressure by liquid separation operation. The obtained crude product was purified by column chromatography (carrier: silica gel, eluent: dichloromethane/ethyl acetate) to obtain 4-{4-(isoquinolin-4-yl)-phenyl }-6-{3-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2-yl)-pyrimidine (compound-86) white powder: 8.1g (63% yield).
[化26]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下34的氫信號。 The following 34 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=9.30(1H)、8.93(1H)、8.84(1H)、8.69(1H)、8.54(1H)、8.40(1H)、8.33(2H)、8.19(1H)、8.06(4H)、7.95(2H)、7.92(2H)、7.89(1H)、7.77-7.60(6H)、7.45(1H)、7.41(2H)、7.37(1H)、7.14(3H)、6.81(2H)、6.75(1H) δ(ppm)=9.30(1H), 8.93(1H), 8.84(1H), 8.69(1H), 8.54(1H), 8.40(1H), 8.33(2H), 8.19(1H), 8.06(4H), 7.95(2H), 7.92(2H), 7.89(1H), 7.77-7.60(6H), 7.45(1H), 7.41(2H), 7.37(1H), 7.14(3H), 6.81(2H), 6.75(1H) )
[實施例10] [Example 10]
<4-{3-(吡啶-3-基)-苯基}-6-{4-(喹啉-8-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-87)之合成> <4-{3-(Pyridin-3-yl)-phenyl}-6-{4-(quinolin-8-yl)-phenyl}-2-(9,9'-spirobis[9H]茀Synthesis of -2-yl)-pyrimidine (Compound-87)>
於反應容器內填裝4-(4-氯-苯基)-6-{3-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶:7.0g、8-喹啉基硼酸:2.2g、參(二亞苄基丙酮)二鈀(0):0.3g、三環己基膦:0.1g、磷酸三鉀:4.5g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,藉分液操作對有機層進行分液萃取及減壓下濃縮。將所得粗製生成物藉由管柱層析法(載體:矽膠,洗提液:二氯甲烷/醋酸乙酯)進行精製,得到4-{3-(吡啶-3-基)-苯基}-6-{4-(喹啉-8-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-87)之白色粉體:4.0g(產率50%)。 Fill the reaction vessel with 4-(4-chloro-phenyl)-6-{3-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2 -Yl)-pyrimidine: 7.0g, 8-quinolinylboronic acid: 2.2g, ginseng (dibenzylideneacetone) dipalladium (0): 0.3g, tricyclohexylphosphine: 0.1g, tripotassium phosphate: 4.5g , On 1,4-Tues Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, the organic layer was separated and extracted and concentrated under reduced pressure by liquid separation operation. The obtained crude product was purified by column chromatography (carrier: silica gel, eluent: dichloromethane/ethyl acetate) to obtain 4-{3-(pyridin-3-yl)-phenyl}- 6-{4-(quinolin-8-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2-yl)-pyrimidine (compound-87) white powder: 4.0 g (50% yield).
[化27]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下34個的氫信號。 The following 34 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=9.00(1H)、8.93(1H)、8.84(1H)、8.69(1H)、8.36(1H)、8.29(2H)、8.24(1H)、8.16(1H)、8.06(1H)、8.03(1H)、8.02(1H)、7.96-7.82(7H)、7.79(1H)、7.73(1H)、7.65(1H)、7.62(1H)、7.46(1H)、7.43(1H)、7.38(3H)、7.13(3H)、6.81(2H)、6.76(1H) δ(ppm)=9.00(1H), 8.93(1H), 8.84(1H), 8.69(1H), 8.36(1H), 8.29(2H), 8.24(1H), 8.16(1H), 8.06(1H), 8.03(1H), 8.02(1H), 7.96-7.82(7H), 7.79(1H), 7.73(1H), 7.65(1H), 7.62(1H), 7.46(1H), 7.43(1H), 7.38(3H) ), 7.13(3H), 6.81(2H), 6.76(1H)
[實施例11] [Example 11]
<4-{3-(吡啶-3-基)-苯基}-6-{4-(喹啉-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-88)之合成> <4-{3-(Pyridin-3-yl)-phenyl}-6-{4-(quinolin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀Synthesis of -2-yl)-pyrimidine (Compound-88)>
於反應容器內填裝4-(4-氯-苯基)-6-{3-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶:7.0g、3-喹啉基硼酸酯:3.3g、參(二亞苄基丙酮)二鈀(0):0.3g、三環己基膦:0.1g、磷酸三鉀:4.5g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,藉分液操作對有機層進行分液萃取及減壓下濃縮。將所得粗製生成物藉由管柱層析法(載體:矽膠,洗提液:二氯甲烷/醋酸乙酯)進行精製,得到4-{3-(吡啶-3-基)-苯基}-6-{4-(喹啉-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-88)之白色粉體:5.2g(產率60%)。 Fill the reaction vessel with 4-(4-chloro-phenyl)-6-{3-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2 -Yl)-pyrimidine: 7.0g, 3-quinolinyl borate: 3.3g, ginseng (dibenzylideneacetone)dipalladium (0): 0.3g, tricyclohexylphosphine: 0.1g, tripotassium phosphate: 4.5g in 1,4-two Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, the organic layer was separated and extracted and concentrated under reduced pressure by liquid separation operation. The obtained crude product was purified by column chromatography (carrier: silica gel, eluent: dichloromethane/ethyl acetate) to obtain 4-{3-(pyridin-3-yl)-phenyl}- 6-{4-(quinolin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2-yl)-pyrimidine (compound-88) white powder: 5.2 g (60% yield).
[化28]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下34個的氫信號。 The following 34 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=9.27(1H)、8.96(1H)、8.86(1H)、8.72(1H)、8.41(2H)、8.36(2H)、8.22(1H)、8.19(1H)、8.08(1H)、8.07(1H)、8.04(1H)、7.99-7.86(7H)、7.79(1H)、7.76(1H)、7.67(2H)、7.48(1H)、7.45(1H)、7.41(2H)、7.16(3H)、6.84(2H)、6.78(1H) δ(ppm)=9.27(1H), 8.96(1H), 8.86(1H), 8.72(1H), 8.41(2H), 8.36(2H), 8.22(1H), 8.19(1H), 8.08(1H), 8.07(1H), 8.04(1H), 7.99-7.86(7H), 7.79(1H), 7.76(1H), 7.67(2H), 7.48(1H), 7.45(1H), 7.41(2H), 7.16(3H) ), 6.84(2H), 6.78(1H)
[實施例12] [Example 12]
<4-{3-(吡啶-3-基)-苯基}-6-{4-(吡啶-4-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-89)之合成> <4-{3-(pyridin-3-yl)-phenyl}-6-{4-(pyridin-4-yl)-phenyl}-2-(9,9'-spirobis[9H]茀- Synthesis of 2-yl)-pyrimidine (Compound-89)>
於反應容器內填裝4-(4-氯-苯基)-6-{3-(吡啶-3-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶:7.0g、4-吡啶基硼酸:1.4g、參(二亞苄基丙酮)二鈀(0):0.3g、三環己基膦:0.1g、磷酸三鉀:4.5g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,藉分液操作對有機層進行分液萃取及減壓下濃縮。將所得粗製生成物藉由管柱層析法(載體:矽膠,洗提液:二氯甲烷/醋酸乙酯)進行精製,得到4-{3-(吡啶-3-基)-苯基}-6-{4-(吡啶-4-基)-苯基}-2-(9,9'-螺雙[9H]茀-2-基)-嘧啶(化合物-89)之白色粉體:6.4g(產率85%)。 Fill the reaction vessel with 4-(4-chloro-phenyl)-6-{3-(pyridin-3-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2 -Yl)-pyrimidine: 7.0g, 4-pyridylboronic acid: 1.4g, ginseng (dibenzylideneacetone)dipalladium (0): 0.3g, tricyclohexylphosphine: 0.1g, tripotassium phosphate: 4.5g, On 1,4-Tues Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, the organic layer was separated and extracted and concentrated under reduced pressure by liquid separation operation. The obtained crude product was purified by column chromatography (carrier: silica gel, eluent: dichloromethane/ethyl acetate) to obtain 4-{3-(pyridin-3-yl)-phenyl}- 6-{4-(pyridin-4-yl)-phenyl}-2-(9,9'-spirobis[9H]茀-2-yl)-pyrimidine (compound-89) white powder: 6.4g (The yield is 85%).
[化29]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下32個的氫信號。 The following 32 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=8.95(1H)、8.84(1H)、8.73(3H)、8.40(1H)、8.31(2H)、8.19(1H)、8.07(1H)、8.05(1H)、8.01(1H)、7.99-7.91(4H)、7.81(2H)、7.76(1H)、7.66(1H)、7.59(2H)、7.49-7.37(4H)、7.16(3H)、6.83(2H)、6.78(1H) δ(ppm)=8.95(1H), 8.84(1H), 8.73(3H), 8.40(1H), 8.31(2H), 8.19(1H), 8.07(1H), 8.05(1H), 8.01(1H), 7.99-7.91(4H), 7.81(2H), 7.76(1H), 7.66(1H), 7.59(2H), 7.49-7.37(4H), 7.16(3H), 6.83(2H), 6.78(1H)
[實施例13] [Example 13]
<2-{4-(萘-1-基)-苯基}-4-{4-(吡啶-3-基)-苯基}-6-{4-(喹啉-3-基)-苯基}-嘧啶(化合物-93)之合成> <2-{4-(Naphthalene-1-yl)-phenyl}-4-{4-(pyridin-3-yl)-phenyl}-6-{4-(quinolin-3-yl)-benzene Synthesis of yl)-pyrimidine (Compound-93)>
於反應容器內填裝4-(4-氯-苯基)-6-{4-(吡啶-3-基)-苯基}-2-{4-(萘-1-基)-苯基}-嘧啶:8.0g、3-喹啉基硼酸酯:4.1g、參(二亞苄基丙酮)二鈀(0):0.4g、三環己基膦:0.4g、碳酸鉀:6.2g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,於系統內加入甲醇,將析出之固體過濾獲得粗製生成物。將所得粗製生成物藉由單氯苯溶媒進行再結晶精製,獲得2-{4-(萘-1-基)-苯基}-4-{4-(吡啶-3-基)-苯基}-6-{4-(喹啉-3-基)-苯基}-嘧啶(化合物-93)之白色粉體:4.8g(產率51%)。 Fill the reaction vessel with 4-(4-chloro-phenyl)-6-{4-(pyridin-3-yl)-phenyl}-2-{4-(naphthalene-1-yl)-phenyl} -Pyrimidine: 8.0g, 3-quinolinyl borate: 4.1g, ginseng (dibenzylideneacetone) dipalladium (0): 0.4g, tricyclohexylphosphine: 0.4g, potassium carbonate: 6.2g, 1,4-Tues Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, methanol was added to the system, and the precipitated solid was filtered to obtain a crude product. The obtained crude product was recrystallized and refined with a monochlorobenzene solvent to obtain 2-{4-(naphthalene-1-yl)-phenyl}-4-{4-(pyridin-3-yl)-phenyl} -White powder of 6-{4-(quinolin-3-yl)-phenyl}-pyrimidine (Compound-93): 4.8 g (yield 51%).
[化30]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下30個的氫信號。 The following 30 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=9.31(1H)、8.99(1H)、8.91(2H)、8.68(1H)、8.51(4H)、8.42(1H)、8.20(1H)、8.16(1H)、8.08-7.88(7H)、7.83(2H)、7.79(1H)7.74(2H)、7.68-7.39(6H) δ(ppm)=9.31(1H), 8.99(1H), 8.91(2H), 8.68(1H), 8.51(4H), 8.42(1H), 8.20(1H), 8.16(1H), 8.08-7.88(7H) ), 7.83(2H), 7.79(1H), 7.74(2H), 7.68-7.39(6H)
[實施例14] [Example 14]
<4-{4-(異喹啉-4-基)-苯基}-2-{4-(萘-1-基)-苯基}-6-{4-(吡啶-3-基)-苯基}-嘧啶(化合物-94)之合成> <4-{4-(isoquinolin-4-yl)-phenyl}-2-{4-(naphthalene-1-yl)-phenyl}-6-{4-(pyridin-3-yl)- Synthesis of phenyl}-pyrimidine (Compound-94)>
於反應容器內填裝4-(4-氯-苯基)-6-{4-(吡啶-3-基)-苯基}-2-{4-(萘-1-基)-苯基}-嘧啶:8.0g、4-異喹啉基硼酸:2.8g、參(二亞苄基丙酮)二鈀(0):0.4g、三環己基膦:0.4g、碳酸鉀:6.2g,於1,4-二烷、H2O混合溶劑下進行迴流攪拌一晚。放冷後,於系統內加入甲醇,將析出之固體過濾獲得粗製生成物。將所得粗製生成物藉由單氯苯溶媒進行再結晶精製,獲得4-{4-(異喹啉-4-基)-苯基}-2-{4-(萘-1-基)-苯基}-6-{4-(吡啶-3-基)-苯基}-嘧啶(化合物-94)之白色粉體:5.1g(產率54%)。 Fill the reaction vessel with 4-(4-chloro-phenyl)-6-{4-(pyridin-3-yl)-phenyl}-2-{4-(naphthalene-1-yl)-phenyl} -Pyrimidine: 8.0g, 4-isoquinolinylboronic acid: 2.8g, ginseng (dibenzylideneacetone) dipalladium (0): 0.4g, tricyclohexylphosphine: 0.4g, potassium carbonate: 6.2g, in 1 ,4-two Reflux and stir overnight in a mixed solvent of alkane and H 2 O. After cooling, methanol was added to the system, and the precipitated solid was filtered to obtain a crude product. The obtained crude product was recrystallized and purified with a monochlorobenzene solvent to obtain 4-{4-(isoquinolin-4-yl)-phenyl}-2-{4-(naphthalene-1-yl)-benzene White powder of yl}-6-{4-(pyridin-3-yl)-phenyl}-pyrimidine (Compound-94): 5.1 g (54% yield).
[化31]
對所得白色粉體使用NMR鑑定構造。 The structure of the obtained white powder was identified by NMR.
以1H-NMR(CDCl3)檢測出以下30個的氫信號。 The following 30 hydrogen signals were detected by 1 H-NMR (CDCl 3 ).
δ(ppm)=9.35(1H)、9.01(1H)、8.93(2H)、8.69(1H)、8.62(1H)、8.54(4H)、8.22(1H)、8.12(1H)、8.03(2H)、7.95(2H)、7.86(2H)、7.80(2H)、7.75(2H)、7.70(2H)、7.65-7.42(6H) δ(ppm)=9.35(1H), 9.01(1H), 8.93(2H), 8.69(1H), 8.62(1H), 8.54(4H), 8.22(1H), 8.12(1H), 8.03(2H), 7.95(2H), 7.86(2H), 7.80(2H), 7.75(2H), 7.70(2H), 7.65-7.42(6H)
[實施例15] [Example 15]
針對一般式(1)所示嘧啶化合物,藉由高感度差示掃描量熱儀(Bruker AXS製、DSC3100SA)測定熔點與玻璃轉移點。結果示於表1。又,「─」表示由於非晶性較高而無法觀測到熔點係蒸鍍性之指標,玻璃轉移點(Tg)為薄膜狀態之穩定性的指標。 For the pyrimidine compound represented by general formula (1), the melting point and glass transition point were measured by a high-sensitivity differential scanning calorimeter (manufactured by Bruker AXS, DSC3100SA). The results are shown in Table 1. In addition, "─" indicates that the melting point-based vapor deposition index cannot be observed due to the high amorphous nature, and the glass transition point (Tg) is an index of the stability of the film state.
[表1]
一般式(1)所示之具有嘧啶環構造的化合物係具有98℃以上的玻璃轉移點,顯示薄膜狀態穩定。 The compound having a pyrimidine ring structure represented by the general formula (1) has a glass transition point above 98°C, indicating a stable film state.
[實施例16] [Example 16]
使用一般式(1)所示之具有嘧啶環構造的化合物,於ITO基板之上製作膜厚100nm的蒸鍍膜,藉由電離電位測定裝置(住友重機械工業股份有限公司製、PYS-202)測定功函數。結果示於表2。功函數為電洞輸送性或電洞阻止性之指標。 Using a compound having a pyrimidine ring structure represented by the general formula (1), a vapor-deposited film with a thickness of 100 nm was formed on an ITO substrate, and measured by an ionization potential measuring device (manufactured by Sumitomo Heavy Industries Co., Ltd., PYS-202) Work function. The results are shown in Table 2. The work function is an indicator of the hole transportability or the hole resistance.
[表2]
一般式(1)所示之具有嘧啶環構造的化合物係具有大於NPD、TPD等一般電洞輸送材料所具有之功函數5.5eV的值,具有較大之電洞阻止能力。 The compound with a pyrimidine ring structure represented by the general formula (1) has a value greater than 5.5 eV of the work function of general hole transport materials such as NPD and TPD, and has a larger hole blocking ability.
[實施例17] [Example 17]
有機EL元件係如圖1所示,於在玻璃基板1上預先形成了作為透明陽極2之ITO電極者上,依序蒸鍍電洞注入層3、電洞輸送層4、發光層5、電洞阻止層6、電子輸送層7、電子注入層8、陰極(鋁電極)9而製作。
The organic EL element is shown in Figure 1. On a
具體而言,將成膜了膜厚50nm之ITO之玻璃基板1,於異丙醇中進行超音波洗淨20分鐘後,於加熱至200℃之加熱板上進行10分鐘乾燥。然後,進行UV臭氧處理15分鐘後,將該具有ITO之玻璃基板安裝在真空蒸鍍機內,減壓至0.001Pa以下。接著,作為覆蓋透明陽極2之電洞注入層3,係將下述構造式的電子受體(Acceptor-1)與下述構造式的化合物(HTM-1)依蒸鍍速度比成為
Acceptor-1:化合物(HTM-1)=3:97的蒸鍍速度進行二元蒸鍍,形成膜厚10nm的電洞注入層3。在此電洞注入層3上,將下述構造式之化合物(HTM-1)形成為膜厚60nm而作為電洞輸送層4。於此電洞輸送層4之上,作為發光層5係將下述構造式的化合物EMD-1與下述構造式的化合物EMH-1以蒸鍍速度比成為EMD-1:EMH-1=5:95之蒸鍍速度進行二元蒸鍍,形成膜厚20nm的發光層5。於此發光層5之上,將本發明實施例1之化合物(化合物-5)與下述構造式之化合物(ETM-1)依蒸鍍速度比成為化合物-5:ETM-1=50:50之蒸鍍速度進行二元蒸鍍,形成膜厚30nm的電洞阻止層兼電子輸送層6及7。於此電洞阻止層兼電子輸送層6及7之上,將氟化鋰形成為膜厚1nm作為電子注入層8。最後,將鋁蒸鍍100nm而形成陰極9。對所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時之發光特性的測定結果整合示表3。
Specifically, the
[化32]
[化33]
[化34]
[實施例18] [Example 18]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例2的化合物(化合物-12),並以蒸鍍速度比成為化合物-12:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例19] [Example 19]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例3的化合物(化合物-19),並以蒸鍍速度比成為化合物-19:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例20] [Example 20]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例4的化合物(化合物-27),並以蒸鍍速度比成為化合物-27:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例21] [Example 21]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例5的化合物(化合物-31),並以蒸鍍速度比成為化合物-31:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例22] [Example 22]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例6的化合物(化合物-36),並以蒸鍍速度比成為化合物-36:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例23] [Example 23]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例7的化合物(化合物-84),並以蒸鍍速度比成為化合物-84:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例24] [Example 24]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例8的化合物(化合物-85),並以蒸鍍速度比成為化合物-85:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例25] [Example 25]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例9的化合物(化合物-86),並以蒸鍍速度比成為化合物-86:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例26] [Example 26]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例10的化合物(化合物-87),並以蒸鍍速度比成為化合物-87:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole blocking layer and
[實施例27] [Example 27]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例11的化合物(化合物-88),並以蒸鍍速度比成為化合物-88:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例28] [Example 28]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例12的化合物(化合物-89),並以蒸鍍速度比成為化合物-89:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例29] [Example 29]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例13的化合物(化合物-93),並以蒸鍍速度比成為化合物-93:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[實施例30] [Example 30]
於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用實施例14的化合物(化合物-94),並以蒸鍍速度比成為化合物-94:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
In Example 17, in addition to substituting the compound of Example 1 (Compound-5) of the present invention as the material of the hole stop layer and
[比較例1] [Comparative Example 1]
為了比較,於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用下述構造式之化合物(ETM-2)(例如參照專利文獻6),並以蒸鍍速度比成為ETM-2:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
For comparison, in Example 17, in addition to substituting the compound of Example 1 of the present invention (Compound-5) as the material of the hole stop layer and
[化35]
[比較例2] [Comparative Example 2]
為了比較,於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用下述構造式之化合物(ETM-3)(例如參照專利文獻8),並以蒸鍍速度比成為ETM-3:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
For comparison, in Example 17, in addition to substituting the compound of Example 1 of the present invention (Compound-5) as the material of the hole stop layer and
[化36]
[比較例3] [Comparative Example 3]
為了比較,於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用下述構造式之化合物(ETM-4)(例如參照專利文獻9),並以蒸鍍速度比成為ETM-4:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
For comparison, in Example 17, in addition to substituting the compound of Example 1 of the present invention (Compound-5) as the material of the hole blocking layer and
[化37]
[比較例4] [Comparative Example 4]
為了比較,於實施例17中,除了取代作為電洞阻止層兼電子輸送層6及7之材料之本發明實施例1化合物(化合物-5),使用下述構造式之化合物(ETM-5)(例如參照專利文獻10),並以蒸鍍速度比成為ETM-5:ETM-1=50:50之蒸鍍速度進行二元蒸鍍以外,其餘以同樣條件製作有機EL元件。對於所製作之有機EL元件,於大氣中、常溫下進行特性測定。對所製作之有機EL元件施加直流電壓時的發光特性的測定結果整合示於表3。
For comparison, in Example 17, in addition to substituting the compound of Example 1 of the present invention (Compound-5) as the material of the hole stop layer and
[化38]
使用實施例17~實施例30及比較例1~比較例4所製作之有機EL元件測定元件壽命,結果整合示於表3。元件壽命係將發光開始時之發光輝度(初期輝度)設為2000cd/m2進行恆定電流驅動時,測定發光輝度衰減至1900cd/m2(相當於將初期輝度設為100%時之95%:95%衰減)為止的時間。 The device life was measured using the organic EL devices produced in Example 17 to Example 30 and Comparative Example 1 to Comparative Example 4. The results are shown in Table 3 together. The life of the device is to set the luminous brightness at the start of light emission (initial brightness) to 2000cd/m 2 for constant current drive, and measure the luminous brightness attenuation to 1900cd/m 2 (equivalent to 95% when the initial brightness is set to 100%: 95% attenuation).
表3
如表1所示,關於流通電流密度10mA/cm2之電流時的驅動電壓,相對於比較例1至比較例4之有機EL元件的3.72~4.01V,於實施例17至實施例30之有機EL元件中低電壓化為3.31~3.59V。 As shown in Table 1, the driving voltage when the current density is 10mA/cm 2 is relative to 3.72~4.01V of the organic EL device of Comparative Example 1 to Comparative Example 4. The organic EL device of Example 17 to Example 30 The low voltage in the EL element is 3.31~3.59V.
於發光效率方面,相對於比較例1至比較例4之有機EL元件的6.59~8.05cd/A,於實施例17至實施例30之有機EL元件則提高為8.21~8.99cd/A。 In terms of luminous efficiency, compared to the 6.59~8.05 cd/A of the organic EL device of Comparative Example 1 to Comparative Example 4, the organic EL device of Example 17 to Example 30 is improved to 8.21~8.99 cd/A.
於電力效率方面,相對於比較例1至比較例4之有機EL元件的5.16~6.62lm/W,實施例17至實施例30之有機EL元件則大幅提高為7.38~8.32lm/W。 In terms of power efficiency, compared to the 5.16~6.62 lm/W of the organic EL devices of Comparative Examples 1 to 4, the organic EL devices of Examples 17 to 30 are greatly improved to 7.38~8.32 lm/W.
於元件壽命(95%減衰)方面,相對於比較例1至比較例4之有機EL元件之165~203小時,於實施例17至實施例30之有機EL元件則大幅長壽化至239~293小時。 In terms of device life (95% attenuation), compared to the 165~203 hours of the organic EL device of Comparative Example 1 to Comparative Example 4, the organic EL device of Example 17 to Example 30 has a significantly longer life to 239~293 hours .
如此,本發明之有機EL元件係發光效率及電力效率優越、且長壽命的有機EL元件。 In this way, the organic EL device of the present invention is an organic EL device having excellent luminous efficiency and power efficiency, and a long life.
(產業上之可利用性) (Industrial availability)
本發明之具有嘧啶環構造之化合物由於電子之注入特性佳、電洞阻止能力優越,且於薄膜狀態下穩定,故適合作為有機EL元件用之化合物。藉由使用該化合物製作有機EL元件,可獲得高效率,且可使驅動電壓降低,並可改善耐久性。可發展於例如家庭電化製品或照明之用途。 The compound with a pyrimidine ring structure of the present invention has good electron injection characteristics, excellent hole blocking ability, and is stable in a thin film state, so it is suitable as a compound for organic EL devices. By using the compound to produce an organic EL element, high efficiency can be obtained, driving voltage can be reduced, and durability can be improved. It can be developed for applications such as household electrical products or lighting.
Claims (14)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018195569 | 2018-10-17 | ||
JP2018-195569 | 2018-10-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202035390A true TW202035390A (en) | 2020-10-01 |
TWI809212B TWI809212B (en) | 2023-07-21 |
Family
ID=70283835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW108137305A TWI809212B (en) | 2018-10-17 | 2019-10-16 | Compound with pyrimidine ring structure and organic electroluminescent device |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220052268A1 (en) |
EP (1) | EP3868748A4 (en) |
JP (1) | JP7406500B2 (en) |
KR (1) | KR20210079267A (en) |
TW (1) | TWI809212B (en) |
WO (1) | WO2020080341A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117343078A (en) | 2021-11-25 | 2024-01-05 | 北京夏禾科技有限公司 | Organic electroluminescent material and device |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG59953A1 (en) | 1993-03-26 | 1999-02-22 | Sumitomo Electric Industries | Organic electroluminescent elements |
DE69412567T2 (en) | 1993-11-01 | 1999-02-04 | Hodogaya Chemical Co Ltd | Amine compound and electroluminescent device containing it |
EP0666298A3 (en) | 1994-02-08 | 1995-11-15 | Tdk Corp | Organic EL element and compound used therein. |
KR100691543B1 (en) | 2002-01-18 | 2007-03-09 | 주식회사 엘지화학 | New material for transporting electron and organic electroluminescent display using the same |
KR101174090B1 (en) | 2008-08-25 | 2012-08-14 | 제일모직주식회사 | Material for organic photoelectric device and organic photoelectric device including the same |
KR101288557B1 (en) | 2008-12-24 | 2013-07-22 | 제일모직주식회사 | Novel compound for organic photoelectric device and organic photoelectric device including the same |
CN102471679A (en) * | 2009-07-10 | 2012-05-23 | 第一毛织株式会社 | Compound for an organic photoelectric element, and an organic photoelectric element comprising the same |
KR20110008619A (en) * | 2009-07-20 | 2011-01-27 | 다우어드밴스드디스플레이머티리얼 유한회사 | Novel organic electroluminescent compounds and organic electroluminescent device using the same |
JP5812584B2 (en) | 2009-09-15 | 2015-11-17 | 東ソー株式会社 | Pyrimidine derivative, method for producing the same, and organic electroluminescent device comprising the same |
KR101979693B1 (en) * | 2010-12-13 | 2019-05-17 | 유디씨 아일랜드 리미티드 | Bispyrimidines for electronic applications |
US9123897B2 (en) | 2011-10-14 | 2015-09-01 | Hodogaya Chemical Co., Ltd. | Benzotriazole derivatives and organic electroluminescent devices using the derivatives |
JP6100368B2 (en) * | 2012-06-14 | 2017-03-22 | ユニバーサル ディスプレイ コーポレイション | Biscarbazole derivative host material and green light emitter for OLED light emitting region |
EP2684932B8 (en) | 2012-07-09 | 2016-12-21 | Hodogaya Chemical Co., Ltd. | Diarylamino matrix material doped with a mesomeric radialene compound |
KR102229862B1 (en) * | 2013-01-22 | 2021-03-22 | 덕산네오룩스 주식회사 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof |
KR102117611B1 (en) * | 2013-06-12 | 2020-06-02 | 삼성디스플레이 주식회사 | Organic light emitting device |
CN103396404B (en) * | 2013-07-31 | 2015-04-22 | 华南理工大学 | Compound using triphenylpyrimidine as core as well as preparation method and application thereof |
JP6182217B2 (en) * | 2013-11-13 | 2017-08-16 | 出光興産株式会社 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE |
KR102201319B1 (en) | 2014-01-14 | 2021-01-11 | 삼성전자주식회사 | Condensed cyclic compound and organic light emitting device including the same |
KR101670056B1 (en) * | 2014-02-20 | 2016-10-28 | 삼성디스플레이 주식회사 | Organic light-emitting device |
JP6501771B2 (en) | 2014-06-11 | 2019-04-17 | 保土谷化学工業株式会社 | Pyrimidine derivative and organic electroluminescent device |
KR102273047B1 (en) | 2014-06-30 | 2021-07-06 | 삼성디스플레이 주식회사 | Organic light-emitting device |
JP2016023135A (en) | 2014-07-16 | 2016-02-08 | 株式会社リコー | Novel pyrimidine derivative and organic electroluminescent element using the same |
JP6390373B2 (en) | 2014-11-18 | 2018-09-19 | コニカミノルタ株式会社 | Transparent electrode, electronic device, and organic electroluminescence element |
KR102295197B1 (en) * | 2014-12-30 | 2021-09-01 | 엘티소재주식회사 | Compound and organic light emitting device using the same |
US20160211454A1 (en) * | 2015-01-20 | 2016-07-21 | Samsung Display Co., Ltd. | Organic light-emitting device |
JP6815320B2 (en) * | 2015-08-27 | 2021-01-20 | 保土谷化学工業株式会社 | Organic electroluminescence device |
KR20180084909A (en) * | 2015-11-17 | 2018-07-25 | 호도가야 가가쿠 고교 가부시키가이샤 | Organic electroluminescent device |
US20200277272A1 (en) * | 2017-09-11 | 2020-09-03 | Hodogaya Chemical Co., Ltd. | Compound having pyrimidine ring structure and organic electroluminescence device |
-
2019
- 2019-10-15 US US17/274,356 patent/US20220052268A1/en active Pending
- 2019-10-15 WO PCT/JP2019/040409 patent/WO2020080341A1/en unknown
- 2019-10-15 KR KR1020217005115A patent/KR20210079267A/en active Search and Examination
- 2019-10-15 JP JP2020553177A patent/JP7406500B2/en active Active
- 2019-10-15 EP EP19872630.9A patent/EP3868748A4/en not_active Withdrawn
- 2019-10-16 TW TW108137305A patent/TWI809212B/en active
Also Published As
Publication number | Publication date |
---|---|
WO2020080341A1 (en) | 2020-04-23 |
JP7406500B2 (en) | 2023-12-27 |
JPWO2020080341A1 (en) | 2021-10-14 |
TWI809212B (en) | 2023-07-21 |
EP3868748A1 (en) | 2021-08-25 |
US20220052268A1 (en) | 2022-02-17 |
CN112654611A (en) | 2021-04-13 |
KR20210079267A (en) | 2021-06-29 |
EP3868748A4 (en) | 2022-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109651406B (en) | Thermally activated delayed fluorescence compound, luminescent material and organic electroluminescent device | |
TWI721379B (en) | Pyrimidine derivatives and organic electroluminescence devices | |
TWI733659B (en) | A pyrimidine derivative and an organic electroluminescent device | |
TWI762696B (en) | Organic electroluminescent element including compound having benzazole ring structure | |
TWI627172B (en) | Novel pyrimidine derivatives and technical field of organic electroluminescent devices | |
TWI743146B (en) | Compound having benzazol ring structure, and organic electroluminescent device | |
TW202041502A (en) | Compound having benzazole ring structure, and organic electroluminescent device | |
TWI750355B (en) | Organic electroluminescent device | |
JP7394050B2 (en) | Compounds with benzimidazole ring structure and organic electroluminescent devices | |
TWI822914B (en) | Compounds with azole ring structure and organic electroluminescent devices | |
TW202138361A (en) | Arylamine compound and electronic apparatus using same | |
TW201412718A (en) | Compound having triphenylene ring structure, and organic electroluminescent device | |
TWI809212B (en) | Compound with pyrimidine ring structure and organic electroluminescent device | |
TWI824763B (en) | Compound having pyrimidine ring structure and organic electroluminescence device | |
TW202222772A (en) | Arylamine compound, organic electroluminescent element, and electronic device | |
TW202106668A (en) | Compound having benzotriazole ring structure and organic electroluminescence element | |
CN112654611B (en) | Compound having pyrimidine ring structure and organic electroluminescent element | |
JP7179734B2 (en) | Compound having indenobenzoazole ring structure and organic electroluminescence device | |
KR20240022707A (en) | Arylamine compound, organic electroluminescence element, and electronic device |